<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">VET</journal-id>
<journal-id journal-id-type="hwp">spvet</journal-id>
<journal-id journal-id-type="nlm-ta">Vet Pathol</journal-id>
<journal-title>Veterinary Pathology</journal-title>
<issn pub-type="ppub">0300-9858</issn>
<issn pub-type="epub">1544-4221</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0300985811429313</article-id>
<article-id pub-id-type="publisher-id">10.1177_0300985811429313</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Infectious Disease</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The Pathology of <italic>Mycobacterium tuberculosis</italic> Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sakamoto</surname>
<given-names>K.</given-names>
</name>
<xref ref-type="aff" rid="aff1-0300985811429313">1</xref>
<xref ref-type="corresp" rid="corresp1-0300985811429313"/>
</contrib>
<aff id="aff1-0300985811429313"><label>1</label>Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA</aff>
</contrib-group>
<author-notes>
<corresp id="corresp1-0300985811429313">K. Sakamoto, Department of Pathology, College of Veterinary Medicine, University of Georgia, 501 D. W. Brooks Dr, Athens, GA 30602-7388 Email: <email>kaoris@uga.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>5</month>
<year>2012</year>
</pub-date>
<volume>49</volume>
<issue>3</issue>
<fpage>423</fpage>
<lpage>439</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">American College of Veterinary Pathologists</copyright-holder>
</permissions>
<abstract>
<p>
<italic>Mycobacterium tuberculosis </italic>is an old enemy of the human race, with evidence of infection observed as early as 5000 years ago. Although more host-restricted than <italic>Mycobacterium bovis</italic>, which can infect all warm-blooded vertebrates, <italic>M. tuberculosis </italic>can infect, and cause morbidity and mortality in, several veterinary species as well. As <italic>M. tuberculosis </italic>is one of the earliest described bacterial pathogens, the literature describing this organism is vast and overwhelming. This review strives to distill what is currently known about this bacterium and the disease it causes for the veterinary pathologist.</p>
</abstract>
<kwd-group>
<kwd>animal models</kwd>
<kwd>Bacille Calmette-Guérin</kwd>
<kwd>granuloma</kwd>
<kwd>
<italic>Mycobacterium tuberculosis</italic>
</kwd>
<kwd> pathogenesis</kwd>
<kwd>tuberculosis</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<disp-quote>
<p>Naturally, we’re disposed to think about diseases just from our own point of view: what can we do to save ourselves and to kill the microbes? Let’s stamp out the scoundrels, and never mind what <italic>their </italic>motives are! In life in general, though, one has to understand the enemy in order to beat him, and that’s especially true in medicine.</p>
<p>—Jared Diamond in <italic>Guns, Germs, and Steel: The Fates of Human Societies</italic>
<sup>
<xref ref-type="bibr" rid="bibr54-0300985811429313">54</xref>
</sup>
</p>
</disp-quote>
<p>Tuberculosis (TB) is an ancient disease with a history interwoven with the evolution and migration of mankind, as well as with the origins of microbiology. The main etiologic agent of TB, <italic>Mycobacterium tuberculosis </italic>(Mtb), is thought to have evolved from an early progenitor in East Africa as early as 3 million years ago.<sup>
<xref ref-type="bibr" rid="bibr90-0300985811429313">90</xref>
</sup> By the early 1800s, TB epidemics ravaged much of Europe and North America, resulting in 800 to 1000 deaths per 100 000 per year.<sup>
<xref ref-type="bibr" rid="bibr120-0300985811429313">120</xref>
</sup> Today, approximately 9 million new cases of TB are identified per year, with almost 2 million deaths related to TB, making Mtb the single greatest cause of mortality due to a bacterial pathogen.<sup>
<xref ref-type="bibr" rid="bibr70-0300985811429313">70</xref>
</sup>
</p>
<p>Mtb is a major component of the history of microbiology. In 1882, Robert Koch demonstrated the tubercle bacillus during a presentation of his famous postulates, which have since set the standard for the demonstration of infectious etiology.<sup>
<xref ref-type="bibr" rid="bibr119-0300985811429313">119</xref>
</sup> Koch also developed tuberculin, a glycerine extract of pure Mtb cultures, which, although a failure in its proposed use as a therapy, could be used to detect latent infections by the measurement of skin reactions at the injection site. Today, tuberculin has been replaced by purified protein derivative (PPD), a precipitate of sterilized Mtb culture filtrate, for testing in humans.</p>
<p>A major breakthrough in the fight against TB occurred when Calmette and Guérin developed the attenuated vaccine strain, Bacille Calmette-Guérin (BCG), through multiple passages of <italic>Mycobacterium bovis </italic>on ox bile and glycerol-soaked potato slices between 1906 and 1919.<sup>
<xref ref-type="bibr" rid="bibr32-0300985811429313">32</xref>
</sup> Although highly effective in preventing the childhood form of TB, the BCG vaccine has variable efficacy in adults.<sup>
<xref ref-type="bibr" rid="bibr67-0300985811429313">67</xref>
</sup> As an attenuated strain, BCG has been enormously useful in TB research because, unlike Mtb, BCG does not require biosafety level 3 facilities. The other major breakthrough was the discovery of the antimycobacterial drugs streptomycin, isoniazid, the rifamycins, and pyrazinamide, in 1944, 1952, 1957, and 1980, respectively.<sup>
<xref ref-type="bibr" rid="bibr207-0300985811429313">207</xref>
</sup> These discoveries led to a new era in TB prevention, research, and treatment.</p>
<p>Today, the absence of a completely protective TB vaccine, the slow development of new antimycobacterial drugs, the need for prolonged therapy regimens, and the emergence of multidrug-resistant (MDR) and extremely drug-resistant (XDR) strains of Mtb are issues that highlight the reemerging TB crisis. The MDR strains account for almost 5% of TB cases.<sup>
<xref ref-type="bibr" rid="bibr70-0300985811429313">70</xref>
</sup> Because veterinary species are infected by Mtb, and because we can apply what is known about Mtb to the fight against <italic>M. bovis</italic>, which has reemerged in the United States and other countries due to persistence within wildlife reservoirs<sup>
<xref ref-type="bibr" rid="bibr218-0300985811429313">218</xref>
</sup> and for which MDR strains have been reported,<sup>
<xref ref-type="bibr" rid="bibr105-0300985811429313">105</xref>
</sup> it is critical that veterinary pathologists have a good basic understanding of Mtb. This review therefore strives to summarize the key components of the microbiology, cell biology, immunology, and pathology of Mtb that are pertinent for the veterinary pathologist.</p>
<sec id="section1-0300985811429313">
<title>The Bacterium</title>
<p>Mycobacteria are nonmotile, nonsporulating, weakly gram-positive, acid-fast bacilli that appear microscopically as straight or slightly curved rods, 1 to 4 μm in length and 0.3 to 0.6 μm wide. Mycobacteria are within the order Actinomycetales, which it shares with bacteria such as <italic>Corynebacterium</italic>,<italic> Nocardia</italic>, and <italic>Rhodococcus</italic>. These bacteria also express unique mycolic acids in the cell envelope that play a critical role in the structure and function of the cell wall.<sup>
<xref ref-type="bibr" rid="bibr14-0300985811429313">14</xref>
</sup> The waxy cell wall confers many of the unique characteristics of this genus: acid-fastness, extreme hydrophobicity, resistance to drying, acidity/alkalinity, and many antibiotics, as well as distinctive immunostimulatory properties.<sup>
<xref ref-type="bibr" rid="bibr45-0300985811429313">45</xref>
</sup>
</p>
<p>Mtb is a member of the slow-growing pathogenic mycobacterial species, characterized by a 12- to 24-hour division rate and prolonged culture period on agar of up to 21 days. Why Mtb grows so slowly is not well understood. Proposed mechanisms include limitation of nutrient uptake through the highly impermeable cell wall and slow rates of RNA synthesis.<sup>
<xref ref-type="bibr" rid="bibr96-0300985811429313">96</xref>
</sup> During experimental infections, its metabolism can shift from an aerobic, carbohydrate-metabolizing mode to one that is microaerophilic and lipid metabolizing.<sup>
<xref ref-type="bibr" rid="bibr25-0300985811429313">25</xref>
</sup> Mycobacteria are facultative intracellular bacteria that multiply within phagocytic cells, particularly macrophages and monocytes. Although many mycobacterial species are environmental, Mtb is strictly parasitic.</p>
<p>Mtb is a member of the <italic>M. tuberculosis </italic>complex, which is defined as the etiologic agents of TB in distinct hosts, and also includes <italic>M. bovis</italic>, <italic>M. africanum</italic>,<italic> M. canetti</italic>, and <italic>M. microti</italic>, with <italic>M. caprae </italic>and <italic>M. pinnipedii </italic>considered variants of <italic>M. bovis</italic>. It was previously assumed that Mtb evolved from <italic>M. bovis </italic>during the domestication of cattle,<sup>
<xref ref-type="bibr" rid="bibr190-0300985811429313">190</xref>
</sup> a theory made widespread by the national bestseller, <italic>Guns, Germs, and Steel</italic>.<sup>
<xref ref-type="bibr" rid="bibr54-0300985811429313">54</xref>
</sup> The genome sequencing projects for both species, however, revealed that <italic>M. bovis </italic>has several DNA deletions while maintaining 99.95% identity with Mtb and no new genetic material,<sup>
<xref ref-type="bibr" rid="bibr31-0300985811429313">31</xref>
</sup> supporting the opposite scenario. Successive DNA deletions of regions of difference (RD) resulted in the branching off of members of the Mtb complex.<sup>
<xref ref-type="bibr" rid="bibr31-0300985811429313">31</xref>
</sup> These genetic analyses indicate that members of the Mtb complex are the clonal progeny of an ancestral strain of <italic>M. canetti</italic>, also referred to as <italic>Mycobacterium prototuberculosis</italic>.<sup>
<xref ref-type="bibr" rid="bibr90-0300985811429313">90</xref>
</sup>
</p>
<p>An important genetic difference between Mtb and BCG is the deletion of 16 loci in the BCG genome, designated RD1 through RD16.<sup>
<xref ref-type="bibr" rid="bibr19-0300985811429313">19</xref>
</sup> RD1, specifically, was the primary deletion in the original attenuation of <italic>M. bovis </italic>to create BCG.<sup>
<xref ref-type="bibr" rid="bibr104-0300985811429313">104</xref>
</sup> RD1 of Mtb is composed of 9 genes, which, together with genes lying outside the RD1 locus, constitute the ESAT-6 secretion system (ESX-1).<sup>
<xref ref-type="bibr" rid="bibr30-0300985811429313">30</xref>
</sup> The major function of RD1 is thought to be the encoding and secretion of the major antigenic proteins, early secretory antigenic target–6 (ESAT-6) and culture filtrate protein–10 (CFP-10),<sup>
<xref ref-type="bibr" rid="bibr109-0300985811429313">109</xref>
</sup> which are discussed in <xref ref-type="table" rid="table1-0300985811429313">Table 1</xref>.</p>
<table-wrap id="table1-0300985811429313" position="float">
<label>Table 1.</label>
<caption>
<p>Virulence Factors of <italic>Mycobacterium tuberculosis</italic>
</p>
</caption>
<graphic alternate-form-of="table1-0300985811429313" xlink:href="10.1177_0300985811429313-table1.tif"/>
<table>
<thead>
<tr>
<th>Factor (Gene)</th>
<th>Mechanism</th>
</tr>
</thead>
<tbody>
<tr>
<td>Proteins</td>
<td>
</td>
</tr>
<tr>
<td>
</td>
<td>
<italic>Immunomodulation</italic>
</td>
</tr>
<tr>
<td> ESAT-6 (esxA) and CFP-10 (esxB)</td>
<td>T cell stimulation, elicitation of DTH<sup>
<xref ref-type="bibr" rid="bibr188-0300985811429313">188</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>Downregulate ROS production in macrophages<sup>
<xref ref-type="bibr" rid="bibr80-0300985811429313">80</xref>
</sup> </td>
</tr>
<tr>
<td>
</td>
<td>Block TLR2-mediated signaling<sup>
<xref ref-type="bibr" rid="bibr161-0300985811429313">161</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>Pore formation, apoptosis,<sup>
<xref ref-type="bibr" rid="bibr53-0300985811429313">53</xref>
</sup> cytolysis<sup>
<xref ref-type="bibr" rid="bibr118-0300985811429313">118</xref>
</sup>
</td>
</tr>
<tr>
<td> α-crystallin (acr)</td>
<td>Antigenic; potential role in triggering latency<sup>
<xref ref-type="bibr" rid="bibr193-0300985811429313">193</xref>
</sup>
</td>
</tr>
<tr>
<td> Antigen 85 complex (fbpA, fbpB, fbpC)</td>
<td>Antigenic; mediates attachment to macrophages<sup>
<xref ref-type="bibr" rid="bibr216-0300985811429313">216</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>
<italic>Intracellular survival/metabolism</italic>
</td>
</tr>
<tr>
<td> Erp (erp)</td>
<td>Required for intracellular growth<sup>
<xref ref-type="bibr" rid="bibr23-0300985811429313">23</xref>
</sup>
</td>
</tr>
<tr>
<td> Cholesterol transporter (Mce4)</td>
<td>Major cholesterol uptake system, important for survival during chronic phase<sup>
<xref ref-type="bibr" rid="bibr158-0300985811429313">158</xref>
</sup>
</td>
</tr>
<tr>
<td> Enzymes and lipid carriers (Igr locus)</td>
<td>Cholesterol metabolism; important for growth<sup>
<xref ref-type="bibr" rid="bibr37-0300985811429313">37</xref>
</sup>
</td>
</tr>
<tr>
<td> Isocitrate lyase (Icl1)</td>
<td>Allows shift to use of fatty acids as major carbon source; important for chronicity, persistence<sup>
<xref ref-type="bibr" rid="bibr140-0300985811429313">140</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>
<italic>Protection against ROI and RNI</italic>
</td>
</tr>
<tr>
<td> Catalase-peroxidase-peroxynitritase (KatG)</td>
<td>
<sup>
<xref ref-type="bibr" rid="bibr135-0300985811429313">135</xref>
</sup>
</td>
</tr>
<tr>
<td> Alkyl-hydroperoxide reductase (ahpC)</td>
<td>
<sup>
<xref ref-type="bibr" rid="bibr186-0300985811429313">186</xref>
</sup>
</td>
</tr>
<tr>
<td> Superoxide dismutases (sodA, sodC)</td>
<td>
<sup>
<xref ref-type="bibr" rid="bibr59-0300985811429313">59</xref>
</sup>
</td>
</tr>
<tr>
<td> Nitric oxide reductase (noxR3)</td>
<td>
<sup>
<xref ref-type="bibr" rid="bibr180-0300985811429313">180</xref>
</sup>
</td>
</tr>
<tr>
<td>Cell wall components</td>
<td>
</td>
</tr>
<tr>
<td> Lipoarabinomannan</td>
<td>
</td>
</tr>
<tr>
<td> Mannose-capped (ManLAM)</td>
<td>Inhibition of DC maturation; induction of IL-10<sup><xref ref-type="bibr" rid="bibr84-0300985811429313">84</xref></sup>
</td>
</tr>
<tr>
<td>

</td>
<td>Inhibition of phagolysosomal fusion<sup>
<xref ref-type="bibr" rid="bibr101-0300985811429313">101</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>Protection against ROI; inhibition of protein kinase C activity; block transcription of IFN-γ-inducible genes<sup>
<xref ref-type="bibr" rid="bibr35-0300985811429313">35</xref>
</sup>
</td>
</tr>
<tr>
<td> Mycolic acids</td>
<td>Role in granuloma formation, macrophage activation<sup>
<xref ref-type="bibr" rid="bibr94-0300985811429313">94</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>Required for mycobacterial survival<sup>
<xref ref-type="bibr" rid="bibr166-0300985811429313">166</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>Biofilm formation<sup>
<xref ref-type="bibr" rid="bibr151-0300985811429313">151</xref>
</sup>
</td>
</tr>
<tr>
<td> Glycopeptidolipids</td>
<td>Biofilm formation<sup>
<xref ref-type="bibr" rid="bibr170-0300985811429313">170</xref>
</sup>
</td>
</tr>
<tr>
<td> Trehalose dimycolate</td>
<td>Granuloma formation, proinflammatory, cachexia<sup>
<xref ref-type="bibr" rid="bibr164-0300985811429313">164</xref>
</sup> </td>
</tr>
<tr>
<td>
</td>
<td>Decrease in NAD<sup>
<xref ref-type="bibr" rid="bibr8-0300985811429313">8</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>Damage to host cell membranes<sup>
<xref ref-type="bibr" rid="bibr122-0300985811429313">122</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>Damage to mitochondria<sup>
<xref ref-type="bibr" rid="bibr114-0300985811429313">114</xref>
</sup>
</td>
</tr>
<tr>
<td>

</td>
<td>Induction of apoptosis<sup>
<xref ref-type="bibr" rid="bibr156-0300985811429313">156</xref>
</sup>
</td>
</tr>
<tr>
<td>
</td>
<td>Inhibition of phagosomal-lysosomal fusion<sup>
<xref ref-type="bibr" rid="bibr10-0300985811429313">10</xref>
</sup>
</td>
</tr>
<tr>
<td> Phenolic glycolipids</td>
<td>Immunosuppression<sup>
<xref ref-type="bibr" rid="bibr171-0300985811429313">171</xref>
</sup>
</td>
</tr>
<tr>
<td> Sulfolipids</td>
<td>Increase macrophage infectivity, impair macrophage activation by inhibiting phagosomal maturation, blocking priming by IFN-γ<sup>
<xref ref-type="bibr" rid="bibr157-0300985811429313">157</xref>
</sup>
</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0300985811429313">
<p>CDP-10, culture filtrate protein–10; DC, dendritic cell; DTH, delayed-type hypersensitivity; ESAT-6, early secretory antigenic target–6; IFN, interferon; IL, interleukin; NAD, nicotinamide adenine dinucleotide; RNI, reactive nitrogen intermediates; ROI, reactive oxygen intermediates; ROS, reactive oxygen species; TLR2, Toll-like receptor 2.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="section2-0300985811429313">
<title>Cell Biology of Mtb</title>
<p>The fate of Mtb in the macrophage is one of the most intriguing aspects of Mtb pathogenesis and deserves explanation before a discussion of virulence factors. Mtb interacts with macrophages through multiple phagocytic receptors (<xref ref-type="fig" rid="fig1-0300985811429313">Fig. 1</xref>; for an older but excellent review, see Ernst<sup>
<xref ref-type="bibr" rid="bibr60-0300985811429313">60</xref>
</sup>). Although macrophage responses to Mtb ligation of any or all of these receptors in vivo are unclear, some in vitro studies show that the ligation of particular receptors may determine the macrophage response. For instance, ligation of the Fc receptor (FcR) led to production of reactive oxygen intermediates (ROIs) and phagosomal-lysosomal fusion, whereas ligation of complement receptor 3 (CR3) or mannose receptor (MR) inhibited the respiratory burst and prevented phagosomal maturation.<sup>
<xref ref-type="bibr" rid="bibr7-0300985811429313">7</xref>,<xref ref-type="bibr" rid="bibr111-0300985811429313">111</xref>
</sup>
</p>
<fig id="fig1-0300985811429313" position="float">
<label>Figure 1.</label>
<caption>
<p>Cell biology of <italic>Mycobacterium tuberculosis </italic>(Mtb) infection. Mtb interacts with macrophages through a number of receptors that have been shown in vitro to differentially regulate the fate of the bacillus. Phagocytic receptors include the Fc receptor (FcR), mannose receptor (MR), complement receptors (CR1, CR3, CR4), surfactant protein receptors (SPR), and scavenger receptors (SR). CD14 is a tethering receptor that aids in Toll-like receptor (TLR) signaling. TLRs are expressed at both the plasma and phagosomal membranes and induce cytokine production via the MyD88 signaling pathway. Mycolylarabinogalactan-peptidoglycan (MAGP) from the Mtb cell wall can be released into the cytoplasm, where it is detected by the pattern recognition receptor, NOD2/CARD15. Both TLR and NOD2 signaling induce cytokine gene transcription via nuclear factor–κB (NF-κB). Once in the phagosome, live Mtb blocks phagosomal maturation (X). The mycobacterial phagosome actively retains the characteristics of an early endosome, such as tryptophan aspartate coat protein (TACO), although this is currently in debate.<sup><xref ref-type="bibr" rid="bibr65-0300985811429313">65</xref></sup> Vacuolar proton ATPase, inducible nitric oxide synthase (iNOS), and natural resistance-associated membrane protein 1 (NRAMP1) are inhibited from associating with this phagosome, thereby avoiding pH reduction, reactive nitrogen intermediates (RNIs), and Fe<sup>2+</sup>/Mn<sup>2+</sup> starvation, respectively.<sup><xref ref-type="bibr" rid="bibr74-0300985811429313">74</xref>,<xref ref-type="bibr" rid="bibr146-0300985811429313">146</xref>,<xref ref-type="bibr" rid="bibr195-0300985811429313">195</xref></sup> Phosphatidylinositol 3-phosphate (PI3P), a lipid involved in proper trafficking of lysosomal constituents to phagosomes, is also continuously eliminated from phagosomes containing live Mtb due to the hydrolytic activity of secreted lipid phosphatase, SapM.<sup><xref ref-type="bibr" rid="bibr211-0300985811429313">211</xref></sup> Early endosomal autoantigen 1 (EEA1) and Hrs, both of which are trafficking molecules that associate with PI3P, are also prevented from associating with the Mtb phagosome.<sup><xref ref-type="bibr" rid="bibr75-0300985811429313">75</xref>,<xref ref-type="bibr" rid="bibr215-0300985811429313">215</xref></sup> The Mtb cell wall component, lipoarabinomannan (LAM), potentially prevents phagosomal maturation through transient inhibition of cytoplasmic Ca<sup>2+</sup> fluxes, which then impairs recruitment of the kinase (hVPS34) that produces PI3P.<sup><xref ref-type="bibr" rid="bibr210-0300985811429313">210</xref></sup> TR, transferrin receptor; LAMP-1, lysosomal-associated membrane protein-1; Rab, small GTPases. Modified from Kaufmann.<sup><xref ref-type="bibr" rid="bibr115-0300985811429313">115</xref></sup>
</p>
</caption>
<graphic alternate-form-of="fig1-0300985811429313" xlink:href="10.1177_0300985811429313-fig1.tif"/>
</fig>
<p>Surface-expressed pattern recognition receptors (PRR), such as Toll-like receptor 2 (TLR2), also bind Mtb and initiate proinflammatory cascades in response to mycobacterial components, such as lipoarabinomannan (LAM), lipomannan, phosphatidylinositol mannosides (PIMs), 19-kDa lipoprotein, and trehalose dimycolate (TDM).<sup>
<xref ref-type="bibr" rid="bibr27-0300985811429313">27</xref>,<xref ref-type="bibr" rid="bibr107-0300985811429313">107</xref>,<xref ref-type="bibr" rid="bibr143-0300985811429313">143</xref>,<xref ref-type="bibr" rid="bibr168-0300985811429313">168</xref>
</sup> TLR4, TLR9, and the TLR adaptor molecule, MyD88, also appear to play important protective roles during Mtb infection in mice, as mice deficient in MyD88 or doubly deficient in TLR2 and TLR4 or TLR9 are more susceptible to infection and have uncontrolled bacterial growth.<sup>
<xref ref-type="bibr" rid="bibr11-0300985811429313">11</xref>,<xref ref-type="bibr" rid="bibr77-0300985811429313">77</xref>,<xref ref-type="bibr" rid="bibr181-0300985811429313">181</xref>
</sup>
</p>
<p>The intracellular PRR, NOD2/CARD15, was shown to recognize the Mtb cell wall component mycolylarabinogalactan-peptidoglycan and to be at least partially required for IL-12p40 responses to this molecule in macrophages and dendritic cells (DCs). NOD2-deficient mice had increased bacterial burdens compared to wild-type mice at 6 months postinfection with Mtb.<sup>
<xref ref-type="bibr" rid="bibr55-0300985811429313">55</xref>
</sup> NOD2 variants have also been demonstrated to be associated with susceptibility to TB in African American populations.<sup>
<xref ref-type="bibr" rid="bibr9-0300985811429313">9</xref>
</sup>
</p>
<p>Both TLRs and NOD2 signal through the NF-κB signaling pathway, and mutations in the leucine zipper domain of NEMO (IκB kinase-γ), which is an activator of this pathway, have been associated with increased susceptibility to mycobacterial disease.<sup>
<xref ref-type="bibr" rid="bibr121-0300985811429313">121</xref>
</sup> These mutations led to profound defects in interleukin (IL)–12 and secondary interferon (IFN)–γ production in monocytes from these patients.<sup>
<xref ref-type="bibr" rid="bibr66-0300985811429313">66</xref>
</sup>
</p>
<p>Internalized Mtb resides in a phagosome, where, in resting macrophages, the bacteria block maturation, lysosomal fusion, and acidification. This inhibition is an active process because dead mycobacteria traffic to the lysosome.<sup>
<xref ref-type="bibr" rid="bibr7-0300985811429313">7</xref>
</sup> Reduced acidification has been attributed to reduced or absent levels of vacuolar proton ATPase.<sup>
<xref ref-type="bibr" rid="bibr195-0300985811429313">195</xref>
</sup> The mycobacterial phagosome retains the characteristics of early endosomes while excluding late endosomal markers.<sup>
<xref ref-type="bibr" rid="bibr40-0300985811429313">40</xref>
</sup> Mycobacterial phagosomes are also prevented from association with inducible nitric oxide synthase (iNOS), thereby limiting exposure to damaging nitrogen radicals.<sup>
<xref ref-type="bibr" rid="bibr146-0300985811429313">146</xref>
</sup> This protective environment also prevents effective antigen processing of Mtb.<sup>
<xref ref-type="bibr" rid="bibr201-0300985811429313">201</xref>
</sup>
</p>
<p>Our understanding of the mechanisms controlling phagosomal maturation is incomplete and controversial. Prevention of mycobacterial phagosome maturation has been attributed to the active retention of tryptophan aspartate coat protein (TACO), as bacilli are readily trafficked to lysosomes and eliminated in TACO-deficient cells, but this is currently in debate.<sup>
<xref ref-type="bibr" rid="bibr65-0300985811429313">65</xref>
</sup> Phosphatidylinositol 3-phosphate (PI3P), a lipid involved in proper trafficking of lysosomal constituents to phagosomes, is also continuously eliminated from phagosomes containing live Mtb.<sup>
<xref ref-type="bibr" rid="bibr211-0300985811429313">211</xref>
</sup> In this study, it was shown that Mtb secretes a lipid phosphatase, SapM, which hydrolyzes PI3P, thereby inhibiting phagosome-late endosome fusion in vitro.</p>
<p>It is likely that Mtb cell wall lipids, such as LAM and TDM, both of which have been shown to prevent phagosomal maturation in vitro,<sup>
<xref ref-type="bibr" rid="bibr10-0300985811429313">10</xref>,<xref ref-type="bibr" rid="bibr76-0300985811429313">76</xref>
</sup> interact directly with the phagosomal membrane to mediate this effect. This likelihood is supported by a recent study that showed that <italic>M. avium</italic> required a closely apposed phagosomal membrane to prevent phagosomal maturation.<sup>
<xref ref-type="bibr" rid="bibr48-0300985811429313">48</xref>
</sup> This study also showed that <italic>M. avium</italic> prevented from closely associating with the phagosomal membrane due to the presence of surface-bound beads, could be rescued from lysosomal conditions when the beads were shed.</p>
<p>Macrophages activated by cytokines such as IFN-γ and tumor necrosis factor (TNF)–α, however, can overcome this mycobacterial defense mechanism, potentially through the stimulation of reactive nitrogen intermediates (RNIs). Nitric oxide (NO), the product of iNOS, is highly toxic to intracellular mycobacteria.<sup>
<xref ref-type="bibr" rid="bibr36-0300985811429313">36</xref>
</sup> The iNOS inhibitors aggravate the course of murine TB, and NOS2-deficient mice are highly susceptible to mycobacterial infection.<sup>
<xref ref-type="bibr" rid="bibr73-0300985811429313">73</xref>,<xref ref-type="bibr" rid="bibr83-0300985811429313">83</xref>
</sup> The role of iNOS in human TB is less clear, although iNOS expression is documented in human monocytes and alveolar macrophages.<sup>
<xref ref-type="bibr" rid="bibr149-0300985811429313">149</xref>
</sup> The role of ROI is even murkier, although mice deficient in cytosolic p47, which is required for effective superoxide production, were partially impaired in controlling acute aerosol infections.<sup>
<xref ref-type="bibr" rid="bibr43-0300985811429313">43</xref>
</sup> This ambiguity may be because certain mycobacterial cell wall components, such as LAM and phenolic glycolipid I, can scavenge oxygen radicals.<sup>
<xref ref-type="bibr" rid="bibr35-0300985811429313">35</xref>,<xref ref-type="bibr" rid="bibr123-0300985811429313">123</xref>
</sup> Amazingly, Mtb forced into phagolysosomes through antibody opsonization can still survive.<sup>
<xref ref-type="bibr" rid="bibr7-0300985811429313">7</xref>
</sup>
</p>
<p>Natural resistance-associated membrane protein 1 (NRAMP1) is a membrane protein involved in innate immunity that is primarily expressed in macrophages and tissues of the reticuloendothelial system. This protein is expressed in the membrane of lysosomes in macrophages and is rapidly recruited to phagosomes.<sup>
<xref ref-type="bibr" rid="bibr87-0300985811429313">87</xref>
</sup> The <italic>NRAMP1</italic> gene (also called <italic>Slc11a1</italic>) has been linked with genetic resistance to BCG and other bacterial infections in the mouse by controlling intracellular microbial replication in macrophages.<sup>
<xref ref-type="bibr" rid="bibr128-0300985811429313">128</xref>
</sup> NRAMP1 does this by acting as an efflux pump for the divalent cations Fe<sup>2+</sup> and Mn<sup>2+</sup>, thereby preventing the use of the cations by the phagocytosed bacteria.<sup>
<xref ref-type="bibr" rid="bibr74-0300985811429313">74</xref>
</sup> Mice strains susceptible to BCG infection carry a point mutation that affects NRAMP1 protein folding, leading to rapid degradation of this protein.<sup>
<xref ref-type="bibr" rid="bibr214-0300985811429313">214</xref>
</sup>
</p>
<p>IFN-γ can also induce autophagy, the process whereby organelles are degraded and recycled, through the induction of p47 GTPases.<sup>
<xref ref-type="bibr" rid="bibr91-0300985811429313">91</xref>
</sup> Induction of autophagy has been shown to lead to the destruction of intracellular Mtb, likely through forced interaction with antimicrobial autolysosomal contents, such as ubiquitin fragments.<sup>
<xref ref-type="bibr" rid="bibr4-0300985811429313">4</xref>
</sup> Autophagy of Mtb can be induced by ligation of PRRs, such as TLRs.<sup>
<xref ref-type="bibr" rid="bibr50-0300985811429313">50</xref>
</sup> Interestingly, Th2 cytokines such as IL-4 and IL-13 both inhibit autophagy and counteract IFN-γ-induced autophagy.<sup>
<xref ref-type="bibr" rid="bibr95-0300985811429313">95</xref>
</sup>
</p>
</sec>
<sec id="section3-0300985811429313">
<title>Virulence Factors</title>
<p>The virulence factors of Mtb can generally be divided into 2 groups: proteins and cell wall components. Because the literature on Mtb virulence factors is vast, the factors that have shown a phenotype in animal models when the gene is deleted or mutated, or for which the mechanisms are well described, are summarized in <xref ref-type="table" rid="table1-0300985811429313">Table 1</xref>.</p>
</sec>
<sec id="section4-0300985811429313">
<title>Pathogenesis and Lesion Development</title>
<p>Human Mtb infections usually begin by inhalation of aerosol droplets containing tubercle bacilli directly expectorated from an individual with “open” pulmonary disease. The infectious dose for a person is reported to be between 1 and 200 bacilli; however, as a single aerosol droplet can contain anywhere from 1 to 400 bacilli, it is unclear what is considered a biologically relevant dose.<sup>
<xref ref-type="bibr" rid="bibr12-0300985811429313">12</xref>,<xref ref-type="bibr" rid="bibr173-0300985811429313">173</xref>
</sup> The bacilli travel to the alveoli, where they are rapidly phagocytosed by alveolar macrophages. These macrophages are stimulated by ligation of TLRs and other PRRs to produce proinflammatory cytokines and chemokines, driving the recruitment of more leukocytes to the site of infection. Neutrophils and monocytes arrive first, phagocytose additional bacteria, secrete more cytokines and chemokines, and begin to organize the early granuloma. Dendritic cells also phagocytose Mtb and then migrate to regional lymph nodes to present mycobacterial antigens to lymphocytes.</p>
<p>Eventually, a well-organized granuloma develops, consisting of central, infected macrophages, surrounded by epithelioid macrophages, foam cells, and occasional multinucleated giant cells of the Langhans type, with peripheral recruited lymphocytes and a fibrous capsule (<xref ref-type="fig" rid="fig2-0300985811429313">Fig. 2a</xref>). This structure is a fine balance between host containment of infection and protection of Mtb from IFN-γ-producing lymphocytes. Over time, the center of the granuloma undergoes necrosis, and the high lipid and protein content of the dead macrophages results in the caseous appearance grossly and histologically (<xref ref-type="fig" rid="fig2-0300985811429313">Fig. 2a</xref>). The granuloma is maintained by a delayed-type hypersensitivity (DTH) response to the persistent presence of antigens and immunostimulatory lipids, as Mtb can survive within macrophages and extracellularly within the granuloma.<sup>
<xref ref-type="bibr" rid="bibr138-0300985811429313">138</xref>
</sup> The caseum is predominantly composed of host-derived lipids, and a recent analysis of gene regulation in the immediately surrounding cells shows Mtb-driven dysregulation of host lipid metabolism.<sup>
<xref ref-type="bibr" rid="bibr117-0300985811429313">117</xref>
</sup> The granuloma environment is considered hypoxic in guinea pigs, rabbits, nonhuman primates, and human beings,<sup>
<xref ref-type="bibr" rid="bibr5-0300985811429313">5</xref>,<xref ref-type="bibr" rid="bibr213-0300985811429313">213</xref>
</sup> which is an important consideration for mycobacterial metabolism and antibiotic therapy efficacy. It was previously believed that Mtb were sparse in the caseum, based on Ziehl-Neelsen acid-fast staining, with most of the detectable bacilli persisting at the periphery.<sup>
<xref ref-type="bibr" rid="bibr126-0300985811429313">126</xref>
</sup> A recently developed acid-fast technique using Auramine O and Rhodamine B revealed that the majority of bacilli are actually in the necrotic core in guinea pig caseous granulomas,<sup>
<xref ref-type="bibr" rid="bibr102-0300985811429313">102</xref>
</sup> but the viability of these bacilli remains unclear. Mtb adapt to this environment by preferentially using fatty acids in their metabolism, slowing down active replication, and increasing cell wall thickness, entering a so-called dormant state.<sup>
<xref ref-type="bibr" rid="bibr26-0300985811429313">26</xref>
</sup>
</p>
<fig id="fig2-0300985811429313" position="float">
<label>Figure 2.</label>
<caption>
<p>Lung; human. (a) The central caseum is surrounded by epithelioid macrophages, multinucleated giant cells, peripheral lymphocytes and plasma cells, and a fibrous capsule. Hematoxylin and eosin (HE). (b) This higher magnification of a portion of (a) contains foamy macrophages (arrows). HE. Courtesy of Dr. M. Kim.</p>
</caption>
<graphic alternate-form-of="fig2-0300985811429313" xlink:href="10.1177_0300985811429313-fig2.tif"/>
</fig>
<p>The lesion at the primary site of implantation is termed the <italic>Ghon focus</italic>. Bacilli may spread before the formation of these organized granulomas via the lymphatics to regional lymph nodes, resulting in granulomatous lymphangitis and lymphadenitis, which, along with the Ghon focus, is called the primary Ranke’s complex. Hematogenous dissemination within the lung or to other organs can also occur during the early stage of this disease. Interestingly, the upper lung lobes of the human favor bacillary growth due to higher oxygen pressure and delayed immune responses.<sup>
<xref ref-type="bibr" rid="bibr160-0300985811429313">160</xref>
</sup>
</p>
<p>Despite wide dissemination of Mtb during primary infection, the majority of infected, but otherwise healthy, individuals resolve these lesions without becoming symptomatic. Approximately 10% of infected individuals, however, develop severe, life-threatening disease or primary progressive disease at this stage.<sup>
<xref ref-type="bibr" rid="bibr41-0300985811429313">41</xref>
</sup> This is believed to be caused by high bacterial load, increased bacterial virulence, immunosuppression, or genetic susceptibility.<sup>
<xref ref-type="bibr" rid="bibr41-0300985811429313">41</xref>
</sup> In most cases, however, the initial infection subsides, and the collagen capsule contracts to form a scar, or the granuloma calcifies. Intriguingly, most TB patients have pulmonary lesions with heterogeneous morphology,<sup>
<xref ref-type="bibr" rid="bibr112-0300985811429313">112</xref>
</sup> suggesting that each granuloma contains bacilli at different stages of latency and reactivation.<sup>
<xref ref-type="bibr" rid="bibr46-0300985811429313">46</xref>,<xref ref-type="bibr" rid="bibr64-0300985811429313">64</xref>
</sup> In chronic lesions, Mtb growth is predominantly in the foamy macrophages at the periphery of lesions or in chronic granulomas that have cavitated and accessed an airway.<sup>
<xref ref-type="bibr" rid="bibr112-0300985811429313">112</xref>
</sup>
</p>
<p>In the absence of progressive disease, an infected individual can remain asymptomatic for years or decades, with bacilli existing in a poorly understood “latent” state, presumably held in check by the host immune system. This ability to establish a chronic asymptomatic infection, followed by reactivation and transmission years later to new uninfected hosts, lends to the tremendous success of Mtb as a pathogen. Any condition affecting the immune system, such as HIV or other infection, old age, malnutrition, malignant disease, immunosuppressive medication, or new infection, can lead to reactivation or secondary disease.<sup>
<xref ref-type="bibr" rid="bibr212-0300985811429313">212</xref>
</sup>
</p>
<p>Five to 10% of latently infected individuals develop secondary disease at some point in their lives for reasons that are not always clear.<sup><xref ref-type="bibr" rid="bibr203-0300985811429313">203</xref></sup> These individuals make up to 80% of clinical TB cases (at least in industrialized countries) and almost all cases of transmission.<sup><xref ref-type="bibr" rid="bibr81-0300985811429313">81</xref></sup> Interestingly, extralesional or extrapulmonary tissues may be persistently infected with Mtb.<sup><xref ref-type="bibr" rid="bibr98-0300985811429313">98</xref>,<xref ref-type="bibr" rid="bibr148-0300985811429313">148</xref></sup> In fact, nearly 15% of reactivating TB cases occur at extrapulmonary sites, such as the central nervous system, the skin, internal organs, and genitourinary tract, without accompanying lung lesions.<sup>
<xref ref-type="bibr" rid="bibr47-0300985811429313">47</xref>
</sup> How reactivation occurs, particularly whether “latent” bacilli become proliferative or if reinfection or bacilli from other sites are responsible for reactivation, are questions that remain to be answered.</p>
<p>The most common form of secondary tuberculosis is usually limited to the lung, and lesions begin as an exudative bronchopneumonia and progress to classical caseous granuloma formation, followed by massive necrosis and cavity formation.<sup>
<xref ref-type="bibr" rid="bibr127-0300985811429313">127</xref>
</sup> Eventually, there is breakdown of the fibrous capsule and communication with airways. These events allow for rapid growth of extracellular bacilli and spread into airways, leading to transmission or intrapulmonary spread.<sup>
<xref ref-type="bibr" rid="bibr33-0300985811429313">33</xref>
</sup> Sputum analysis during this phase of TB reveals increases in macrophages and neutrophils.<sup>
<xref ref-type="bibr" rid="bibr155-0300985811429313">155</xref>
</sup>
</p>
<p>Although symptoms of primary TB in most cases are generally subtle and easily overlooked, secondary cases are characterized by localized symptoms, such as coughing, hemoptysis, and pleuritic pain, as well as the generalized symptoms of fever, anorexia, night sweats, and cachexia. This propensity of TB to cause wasting away of patients garnered it the name <italic>consumption</italic>. In immunocompetent individuals, secondary TB can result in dissemination and death in 50% of cases and chronicity in 25% to 30% of cases. If the host is able to reestablish immune control over the disease, recovery is also possible, as is seen in 20% to 25% of cases.<sup>
<xref ref-type="bibr" rid="bibr15-0300985811429313">15</xref>
</sup>
</p>
</sec>
<sec id="section5-0300985811429313">
<title>Host Response</title>
<sec id="section6-0300985811429313">
<title>Cytokines</title>
<p>After phagocytosis of inhaled Mtb, alveolar macrophages are stimulated, primarily by ligation of TLR2 and TLR4, to secrete proinflammatory cytokines, such as TNF-α, IL-1β, IL-6, and IL-12.<sup>
<xref ref-type="bibr" rid="bibr28-0300985811429313">28</xref>,<xref ref-type="bibr" rid="bibr143-0300985811429313">143</xref>
</sup> TNF-α is a critical cytokine in the response to Mtb in that it can stimulate neutrophils and macrophages in an autocrine and paracrine fashion to stimulate apoptosis and ROI/RNI production, leading to the destruction of some phagocytosed bacilli.<sup>
<xref ref-type="bibr" rid="bibr79-0300985811429313">79</xref>
</sup> TNF-α is also an essential cytokine in driving organized granuloma formation, and the recent development of anti-TNF-α drugs for the treatment of chronic inflammatory conditions has led to increased TB reactivation cases.<sup>
<xref ref-type="bibr" rid="bibr72-0300985811429313">72</xref>
</sup> The role of TNF-α in granuloma formation is in part due to its own leukocyte recruitment activity, as well as TNF-α-dependent chemokine production.<sup>
<xref ref-type="bibr" rid="bibr3-0300985811429313">3</xref>
</sup> TNF-α is also at least partially responsible for the fever and wasting that occur in progressive TB.<sup>
<xref ref-type="bibr" rid="bibr72-0300985811429313">72</xref>
</sup>
</p>
<p>IL-1β has also been shown to play an important role in granuloma formation and has been correlated to disease activity and fever in infected patients.<sup>
<xref ref-type="bibr" rid="bibr63-0300985811429313">63</xref>,<xref ref-type="bibr" rid="bibr202-0300985811429313">202</xref>
</sup> IL-1 also acts in an autocrine and paracrine fashion to stimulate macrophages to produce TNF-α and IL-6 and upregulates T cell expression of IL-2 and its receptor, thus stimulating T cell proliferation.<sup>
<xref ref-type="bibr" rid="bibr200-0300985811429313">200</xref>
</sup> IL-1α has shown some use as a biomarker for patients with pulmonary TB when used in combination with MIP-1β and epidermal growth factor.<sup>
<xref ref-type="bibr" rid="bibr38-0300985811429313">38</xref>
</sup>
</p>
<p>IL-6 is produced in large amounts in the pleural fluid and bronchoalveolar lavage cells from TB patients, but this cytokine tends to antagonize the effects of TNF-α by preventing binding of TNF-α to macrophages and antagonizing its antimycobacterial activity.<sup>
<xref ref-type="bibr" rid="bibr21-0300985811429313">21</xref>,<xref ref-type="bibr" rid="bibr202-0300985811429313">202</xref>,<xref ref-type="bibr" rid="bibr220-0300985811429313">220</xref>
</sup> IL-6 has also been shown to enhance mycobacterial growth both intra- and extracellularly<sup>
<xref ref-type="bibr" rid="bibr52-0300985811429313">52</xref>
</sup> while inhibiting TNF-α and IL-1β production at the transcriptional level in vitro.<sup>
<xref ref-type="bibr" rid="bibr183-0300985811429313">183</xref>
</sup> IL-6 also suppresses T cell proliferation and IL-2 production in response to antigenic stimulation.<sup>
<xref ref-type="bibr" rid="bibr208-0300985811429313">208</xref>
</sup>
</p>
<p>IL-12 is an important cytokine driving T helper type 1 (Th1) differentiation and IFN-γ production, which is required for resistance to mycobacteria and other intracellular pathogens.<sup>
<xref ref-type="bibr" rid="bibr42-0300985811429313">42</xref>
</sup> IL-12 also enhances cytotoxicity by stimulating the proliferation of antigen-specific cytolytic T cells and natural killer (NK) cells.<sup>
<xref ref-type="bibr" rid="bibr22-0300985811429313">22</xref>
</sup> The importance of IL-12 is highlighted by cases of severe nontuberculous mycobacterial disease in patients with autosomal recessive mutations in the genes encoding either IL-12 or its receptor, IL-12Rβ1, most likely via decreased production of IFN-γ.<sup>
<xref ref-type="bibr" rid="bibr58-0300985811429313">58</xref>
</sup>
</p>
<p>IFN-γ, a T cell cytokine that activates macrophages to produce reactive oxygen and nitrogen species, is probably the most important cytokine in the immune response to mycobacteria. This cytokine is mainly secreted by Th1 and CD8<sup>+</sup> cytotoxic lymphocytes, NK cells, natural killer T (NKT) cells (cells with characteristics of both NK and T cells), professional antigen-presenting cells (APCs), and, to a lesser extent, B cells.<sup>
<xref ref-type="bibr" rid="bibr136-0300985811429313">136</xref>
</sup> Mice defective in IFN-γ or its receptor are extremely susceptible to Mtb and BCG, with earlier death, high bacterial numbers, and progressive destructive granuloma formation.<sup>
<xref ref-type="bibr" rid="bibr71-0300985811429313">71</xref>,<xref ref-type="bibr" rid="bibr110-0300985811429313">110</xref>
</sup> Patients with genetic defects in IFN-γ receptor function or its signaling pathway (ie, STAT1) are particularly prone to chronic or uncontrolled nontuberculous mycobacterial infections.<sup>
<xref ref-type="bibr" rid="bibr58-0300985811429313">58</xref>
</sup> Furthermore, treatment of these patients with exogenous IFN-γ can lead to clinical improvement.<sup>
<xref ref-type="bibr" rid="bibr103-0300985811429313">103</xref>
</sup> Failure of AIDS patients to produce high levels of IFN-γ in the lung during pulmonary TB most likely contributes to their susceptibility to infection with Mtb.<sup>
<xref ref-type="bibr" rid="bibr124-0300985811429313">124</xref>
</sup>
</p>
<p>A separate subset of T cells, termed Th17 cells, which produce IL-17A, IL-17F, IL-21, and IL-22, has been recently described.<sup>
<xref ref-type="bibr" rid="bibr159-0300985811429313">159</xref>
</sup> IL-17, in particular, has been shown to play an important role in the immunopathology of autoimmune disorders and chronic infectious diseases,<sup>
<xref ref-type="bibr" rid="bibr56-0300985811429313">56</xref>,<xref ref-type="bibr" rid="bibr57-0300985811429313">57</xref>
</sup> mostly by the induction of chemokines and therefore excessive recruitment of leukocytes to the site of infection, with ensuing tissue damage.<sup>
<xref ref-type="bibr" rid="bibr154-0300985811429313">154</xref>
</sup> This cytokine is produced primarily by γδ T cells in mice, in response to IL-6 and IL-23 during mycobacterial infection.<sup>
<xref ref-type="bibr" rid="bibr129-0300985811429313">129</xref>
</sup> Studies in human DCs suggest that prior to IFN-γ production during Mtb infection, IL-23 is preferentially produced, suggesting early skewing toward a Th17 response.<sup>
<xref ref-type="bibr" rid="bibr85-0300985811429313">85</xref>
</sup> In the absence of IL-17, neutrophils are found in lesser numbers, and granuloma formation in response to BCG is delayed,<sup>
<xref ref-type="bibr" rid="bibr205-0300985811429313">205</xref>
</sup> suggesting a role for this cytokine in the initial formation of the granuloma. It is likely that a proper Th1-Th17 balance is required for control of Mtb.</p>
<p>Immunosuppressive cytokines such as IL-10 and transforming growth factor (TGF)–β, both of which suppress effective Th1 responses, play a role in active TB and tend to be transiently overexpressed in TB patients.<sup>
<xref ref-type="bibr" rid="bibr100-0300985811429313">100</xref>
</sup> Higher numbers of regulatory T cells, which produce these immunosuppressive cytokines, were reported in the peripheral blood of TB patients and at the site of infection.<sup>
<xref ref-type="bibr" rid="bibr92-0300985811429313">92</xref>
</sup> TGF-β is also associated with fibrosis during chronic Mtb infection.<sup>
<xref ref-type="bibr" rid="bibr97-0300985811429313">97</xref>
</sup> IL-27, a member of the IL-12 cytokine family, has been shown to negatively regulate development of Th17-type cells during chronic inflammation.<sup>
<xref ref-type="bibr" rid="bibr194-0300985811429313">194</xref>
</sup> Improved control of mycobacterial growth due to increased inflammatory cytokine responses in the lungs of mice lacking IL-27 receptor signaling has been reported.<sup>
<xref ref-type="bibr" rid="bibr162-0300985811429313">162</xref>
</sup>
</p>
<p>IL-4 and other Th2 cytokines are elevated in patients with active TB, and high pulmonary IL-4 expression has correlated with cavitation.<sup>
<xref ref-type="bibr" rid="bibr206-0300985811429313">206</xref>
</sup> IL-4 has a pathogenic role during late TB disease by downregulating protective Th1 responses.<sup>
<xref ref-type="bibr" rid="bibr24-0300985811429313">24</xref>
</sup> Th2-skewed responses are also more commonly observed in TB patients living closer to the equator, possibly due to helminth coinfection, high exposure to saprophytic mycobacteria, or higher Mtb inoculum.<sup>
<xref ref-type="bibr" rid="bibr99-0300985811429313">99</xref>
</sup> This effect may be responsible for the uneven efficacy of BCG vaccination in different parts of the world.<sup>
<xref ref-type="bibr" rid="bibr179-0300985811429313">179</xref>
</sup>
</p>
</sec>
<sec id="section7-0300985811429313">
<title>Cellular Response</title>
<p>TB and DTH lesions are thought to be examples of granulomas composed of classically activated macrophages, also referred to as M1 macrophages, in that they develop in response to concomitant stimulation with IFN-γ and microbial products.<sup>
<xref ref-type="bibr" rid="bibr2-0300985811429313">2</xref>
</sup> Although Mtb contains several components known to ligate TLRs, which usually results in innately activated macrophages, infection elicits robust IL-12 production, supporting the M1 phenotype. These activated macrophages compose the majority of epithelioid macrophages within TB granulomas. The Langhans-type multinucleated giant cells, typical of Mtb granulomas, are the result of fusion of epithelioid macrophages and have recently been shown to be induced by the cell wall lipid lipomannan.<sup>
<xref ref-type="bibr" rid="bibr167-0300985811429313">167</xref>
</sup> Foamy macrophages (<xref ref-type="fig" rid="fig2-0300985811429313">Fig. 2b</xref>, arrows) predominate in advanced TB and are only induced by virulent mycobacteria in response to oxygenated mycolic acids.<sup>
<xref ref-type="bibr" rid="bibr165-0300985811429313">165</xref>
</sup> These cells are thought to provide a nutrient-rich, protective reservoir for Mtb persistence, as these cells have reduced microbicidal and phagocytic activity. Foamy macrophages can also induce apoptosis of Th1 cells through the Fas/Fas ligand mechanism while suppressing their own apoptosis through high expression of the antiapoptotic Bcl2 molecule.<sup>
<xref ref-type="bibr" rid="bibr176-0300985811429313">176</xref>
</sup>
</p>
<p>Neutrophils are one of the first responders to Mtb infection, and although their bactericidal activities, such as phagocytosis, ROI, RNI, antimicrobial peptides, and extracellular traps, are well characterized, their role in the immune response to Mtb is quite controversial. In mouse models, depletion of neutrophils was shown to lead to an increase in mycobacterial growth, whereas stimulation of neutrophilia led to decreases.<sup>
<xref ref-type="bibr" rid="bibr78-0300985811429313">78</xref>
</sup> There are conflicting reports, however, regarding the ability of neutrophils to kill mycobacteria directly.<sup>
<xref ref-type="bibr" rid="bibr51-0300985811429313">51</xref>,<xref ref-type="bibr" rid="bibr108-0300985811429313">108</xref>
</sup> Nevertheless, neutrophils do play a role in cytokine and chemokine production, granuloma formation, and transference of microbicidal molecules to neighboring, infected macrophages.<sup>
<xref ref-type="bibr" rid="bibr174-0300985811429313">174</xref>,<xref ref-type="bibr" rid="bibr185-0300985811429313">185</xref>,<xref ref-type="bibr" rid="bibr197-0300985811429313">197</xref>
</sup> Neutrophilic inflammation may also be an important part of TB immunopathology, in that there is greater neutrophil accumulation within lesions in TB-susceptible versus resistant animals.<sup>
<xref ref-type="bibr" rid="bibr61-0300985811429313">61</xref>
</sup> This effect has recently been shown to be due to differential chemokine expression between these 2 models and may explain the earlier discrepancies in neutrophil studies.<sup>
<xref ref-type="bibr" rid="bibr116-0300985811429313">116</xref>
</sup> Neutrophils have also been shown to be the predominant infected cell type in active TB patients, suggesting a permissive environment for bacillary replication.<sup>
<xref ref-type="bibr" rid="bibr62-0300985811429313">62</xref>
</sup>
</p>
<p>Type 1 and 2 pneumocytes, as well as pulmonary fibroblasts and endothelial cells, have been reported to contain mycobacterial DNA in TB patients,<sup>
<xref ref-type="bibr" rid="bibr98-0300985811429313">98</xref>
</sup> and both pneumocytes and alveolar endothelial cells can be infected in vitro,<sup>
<xref ref-type="bibr" rid="bibr144-0300985811429313">144</xref>
</sup> but the role of these cells in disease is unclear. Mtb was shown in vitro to enter type 1 pneumocytes by macropinocytosis.<sup>
<xref ref-type="bibr" rid="bibr82-0300985811429313">82</xref>
</sup> The M cells overlying the luminal aspect of bronchiolar-associated lymphoid tissue is also a proposed site of entry for Mtb.<sup>
<xref ref-type="bibr" rid="bibr199-0300985811429313">199</xref>
</sup> As mentioned in <xref ref-type="table" rid="table1-0300985811429313">Table 1</xref>, ESAT-6 is cytolytic for type 1 pneumocytes,<sup>
<xref ref-type="bibr" rid="bibr118-0300985811429313">118</xref>
</sup> and necrosis of alveolar epithelium was shown to be a characteristic of virulent Mtb infection.<sup>
<xref ref-type="bibr" rid="bibr139-0300985811429313">139</xref>
</sup> Both mouse and human lung and tracheal epithelial cells have been shown to express defensins after infection with Mtb, with data supporting a protective role by these cationic peptides.<sup>
<xref ref-type="bibr" rid="bibr177-0300985811429313">177</xref>,<xref ref-type="bibr" rid="bibr178-0300985811429313">178</xref>
</sup>
</p>
<p>Dendritic cells in the lung can phagocytose Mtb that has crossed the epithelial barrier. Mtb enters by binding the receptor DC-SIGN via the cell wall component ManLAM, with a lesser role played by CR3 and MR.<sup>
<xref ref-type="bibr" rid="bibr196-0300985811429313">196</xref>
</sup> After phagocytosis, the DCs mature and migrate to regional lymph nodes, where they present mycobacterial antigens in the context of major histocompatibility complex (MHC) molecules, as well as CD1, to prime CD4<sup>+</sup> and CD8<sup>+</sup> T cells.<sup>
<xref ref-type="bibr" rid="bibr13-0300985811429313">13</xref>,<xref ref-type="bibr" rid="bibr89-0300985811429313">89</xref>
</sup> Dendritic cells infected with Mtb have an impaired ability to present lipid antigens, possibly due to delay of maturation mediated by cell wall components, and are retained at the lung for prolonged periods compared to DCs that have taken up model antigens.<sup>
<xref ref-type="bibr" rid="bibr163-0300985811429313">163</xref>
</sup> Interestingly, it has been shown in vitro that more virulent strains of Mtb, the Beijing strains in particular, inhibit the maturation of DCs and the ability of DCs to present lipid antigens through decreased expression of CD1.<sup>
<xref ref-type="bibr" rid="bibr192-0300985811429313">192</xref>
</sup>
</p>
<p>The activated T cells specific for mycobacterial antigens migrate to the lungs to participate in granuloma formation. The localized immune response to Mtb or the tuberculin reaction is the classical model for DTH. Mycobacterial antigens drive the differentiation of CD4<sup>+</sup> T cells to Th1 cells. Th1 cells preferentially secrete IFN-γ, which is responsible for the development of DTH via macrophage activation. IL-12 is also critical for the induction of Th1 and IFN-γ responses and therefore DTH. Other important cytokines in this response are IL-2, which causes proliferation of the Th1 cells, and TNF-α and lymphotoxin, which mediate many of the vasodilatory effects and induce the secretion of more chemokines to recruit leukocytes to the reaction site. CD4<sup>+</sup> T cells are important in the prevention of reactivation and both primary and secondary disease, as decreased CD4<sup>+</sup> T cells accelerate TB in HIV patients.<sup>
<xref ref-type="bibr" rid="bibr219-0300985811429313">219</xref>
</sup> CD4<sup>+</sup> T cells are also relatively absent in cavitated TB lesions, HIV/TB coinfected patients are less likely to have cavitary disease,<sup>
<xref ref-type="bibr" rid="bibr29-0300985811429313">29</xref>
</sup> and CD4-deficient mice have less necrosis in <italic>M. </italic>avium–induced lesions,<sup>
<xref ref-type="bibr" rid="bibr69-0300985811429313">69</xref>
</sup> suggesting a role for CD4<sup>+</sup> T cells in cavitation. CD4<sup>+</sup> T cells in the bronchoalveolar lavage (BAL) fluid of patients with cavitary disease are also more Th2-skewed, secreting more IL-4 than IFN-γ.<sup>
<xref ref-type="bibr" rid="bibr206-0300985811429313">206</xref>
</sup>
</p>
<p>αβ T cell receptor (TCR)–expressing CD4<sup>+</sup> T cells are required for granuloma formation; transfer of these cells, but not CD8<sup>+</sup> T cells, can protect immunodeficient mice from Mtb.<sup>
<xref ref-type="bibr" rid="bibr44-0300985811429313">44</xref>
</sup> CD4<sup>+</sup> T cells may also reduce bacterial numbers by the induction of apoptosis through the Fas (CD95) ligand system.<sup>
<xref ref-type="bibr" rid="bibr150-0300985811429313">150</xref>
</sup> CD8<sup>+</sup> T cells do play an important role, however, by destroying infected cells or killing intracellular bacteria via the secretion of granulysin and perforin, which lyse host cells and attack Mtb directly.<sup>
<xref ref-type="bibr" rid="bibr191-0300985811429313">191</xref>
</sup> Recent studies in the nonhuman primate model, show an important role for CD8<sup>+</sup> T cells in that both BCG-vaccinated or previously infected and antibiotic-cured rhesus macaques had markedly reduced protection against challenge with Mtb after CD8<sup>+</sup> T cell depletion.<sup>
<xref ref-type="bibr" rid="bibr39-0300985811429313">39</xref>
</sup>
</p>
<p>The CD1 family is composed of MHC class I–like molecules that bind distinct lipid antigens, particularly glycolipids, which are recognized by T cells.<sup>
<xref ref-type="bibr" rid="bibr17-0300985811429313">17</xref>
</sup> CD1 molecules are therefore of great interest to TB researchers because Mtb abundantly releases lipid antigens during infection.<sup>
<xref ref-type="bibr" rid="bibr16-0300985811429313">16</xref>
</sup> CD1 molecules have been implicated in the presentation of mycobacterial lipids and the immune response to Mtb. CD1d binds and presents the phosphatidylinositol mannoside, PIM<sub>4</sub>, to invariant NKT cells, which have recently been shown to be able to suppress intracellular Mtb replication both in vitro and in vivo through the innate production of IFN-γ in response to infection.<sup>
<xref ref-type="bibr" rid="bibr68-0300985811429313">68</xref>,<xref ref-type="bibr" rid="bibr182-0300985811429313">182</xref>
</sup> Mycobacterial diacylated sulfoglycolipids were shown to be presented by CD1b molecules and to stimulate specific T cells to recognize Mtb-infected cells and kill intracellular bacteria.<sup>
<xref ref-type="bibr" rid="bibr86-0300985811429313">86</xref>
</sup> CD1b molecules also present free mycolic acids and LAM.<sup>
<xref ref-type="bibr" rid="bibr17-0300985811429313">17</xref>,<xref ref-type="bibr" rid="bibr187-0300985811429313">187</xref>
</sup> Treatment of mice with anti-CD1 antibody resulted in exacerbated early pathology and decreased reduction of type 1 cytokines after Mtb infection, although CD1d-deficient mice showed no greater susceptibility to infection.<sup>
<xref ref-type="bibr" rid="bibr18-0300985811429313">18</xref>
</sup> In the context of human infection, CD1-restricted T cell responses to mycobacterial lipid preparations were observed in Mtb-infected individuals.<sup>
<xref ref-type="bibr" rid="bibr204-0300985811429313">204</xref>
</sup>
</p>
<p>Natural killer cells are also mycobactericidal and can be activated in the absence of APCs. Stimulated NK cells secrete IFN-γ, IL-15, and IL-18, which play a crucial role in the regulation of CD8<sup>+</sup> T cells during Mtb infection.<sup>
<xref ref-type="bibr" rid="bibr209-0300985811429313">209</xref>
</sup> Natural killer cells also improve the cytolytic activity of γδ T cells and induce them to secrete IFN-γ.<sup>
<xref ref-type="bibr" rid="bibr222-0300985811429313">222</xref>
</sup>
</p>
<p>Although cell-mediated immunity is far more critical for effective responses against Mtb, B cells and antibodies have been shown to play a role during TB. B cell–deficient mice were shown to have higher bacillary burden and exacerbated pulmonary lesions due to higher neutrophil recruitment after aerosol infection with Mtb.<sup>
<xref ref-type="bibr" rid="bibr132-0300985811429313">132</xref>
</sup> Passive immunization of Mtb-infected SCID mice with sera from mice treated with Mtb extracts also reduced the number of bacilli in the lungs and the extent of granulomatous infiltration.<sup>
<xref ref-type="bibr" rid="bibr88-0300985811429313">88</xref>
</sup> Treatment with antibodies specific for particular Mtb components, such as 19-kDa lipoprotein,<sup>
<xref ref-type="bibr" rid="bibr130-0300985811429313">130</xref>
</sup> α-crystallin,<sup>
<xref ref-type="bibr" rid="bibr217-0300985811429313">217</xref>
</sup> and LAM,<sup>
<xref ref-type="bibr" rid="bibr93-0300985811429313">93</xref>
</sup> resulted in reduction of bacterial load and lesions in the lungs of infected mice. Antibody-opsonized mycobacteria are more efficiently internalized and killed by neutrophils and macrophages<sup>
<xref ref-type="bibr" rid="bibr49-0300985811429313">49</xref>
</sup> and more effectively processed for antigen presentation by DCs.<sup>
<xref ref-type="bibr" rid="bibr198-0300985811429313">198</xref>
</sup> Interestingly, although antibody production is typically associated with a shift to a Th2 response, BCG-induced antibodies were shown to enhance proliferation of IFN-γ production in mycobacterium-specific CD4+ and CD8+ T cells.<sup>
<xref ref-type="bibr" rid="bibr49-0300985811429313">49</xref>
</sup> Unfortunately, diagnostic testing for antibody responses to Mtb components has poor sensitivity and specificity, rendering these tests relatively ineffective.<sup>
<xref ref-type="bibr" rid="bibr1-0300985811429313">1</xref>
</sup>
</p>
</sec>
</sec>
<sec id="section8-0300985811429313">
<title>Animal Models of TB</title>
<p>The following is a description of animal models of TB that specifically use Mtb. There are several important TB models using <italic>Mycobacterium marinum </italic>(zebrafish) and <italic>M. bovis </italic>(rabbits, swine, calves), for which the reader is directed to other reviews.</p>
<sec id="section9-0300985811429313">
<title>Mice</title>
<p>The study of TB in laboratory animals has been challenging in that mice, for which the most reagents are available, are relatively resistant to Mtb and do not typically develop TB or a DTH response to Mtb in a manner similar to humans. Mice can be infected by aerosol, but their more complicated nasal scrolls, relative to humans, affect the final dose that is administered to the lungs.<sup>
<xref ref-type="bibr" rid="bibr172-0300985811429313">172</xref>
</sup> Furthermore, mice can harbor high numbers of Mtb within lung tissue without showing clinical signs.<sup>
<xref ref-type="bibr" rid="bibr141-0300985811429313">141</xref>
</sup> Mice also do not cough or form cavitary lesions, making them a poor model for transmission studies.<sup>
<xref ref-type="bibr" rid="bibr113-0300985811429313">113</xref>
</sup> It is important to recognize, however, that the mouse model has been critical in the development of the standard anti-TB therapy that is used today (for an excellent review of this history, see Mitchison<sup>
<xref ref-type="bibr" rid="bibr147-0300985811429313">147</xref>
</sup>) and is still a required step in the development of new vaccines.</p>
<p>The histologic appearance of lesions in mice infected with Mtb by aerosol typically consists of multifocal aggregates of epithelioid and foamy, infected macrophages, with scattered multinucleated giant cells, lymphocytes, and plasma cells flooding alveoli, with significant lymphoplasmacytic perivascular cuffing. Often, there is the appearance of “inverted” granulomas, where the lymphocytes and plasma cells are centrally located, surrounding a venule or arteriole, with the infected macrophages located peripherally. This has potential significance for the pathogenesis of Mtb in mice, in that the centrally located, IFN-γ-producing T cells have greater access to the infected macrophages and may thus allow for better control of infection and reduced necrosis.<sup>
<xref ref-type="bibr" rid="bibr153-0300985811429313">153</xref>
</sup> Fibrous capsules are also not observed histologically, which can affect the validity of antibiotic studies, as Mtb would be more easily accessed by drugs in the mouse lung. Nonetheless, chronic infection can be experimentally produced in mice, and caseous granulomas have been shown in sensitized mice in response to Mtb when infections were in proximity to lipids, such as adipose tissue or if preceded by lipid pneumonia,<sup>
<xref ref-type="bibr" rid="bibr106-0300985811429313">106</xref>
</sup> or in certain mouse strains, such as I/St.<sup>
<xref ref-type="bibr" rid="bibr169-0300985811429313">169</xref>
</sup> Necrotizing and cavitating granulomas with fibrosis can also be produced in mice by infection with <italic>M. avium</italic>, but in this model, infection is never controlled and bacillary burden increases until death.<sup>
<xref ref-type="bibr" rid="bibr20-0300985811429313">20</xref>
</sup> In addition, because of their short life span, mice are poor models for the study of latent infection. Latency can be studied to a degree using the Cornell mouse model, in which mice are treated with antibiotics until a paucibacillary state of infection is reached, followed by immunosuppression by steroid administration.<sup>
<xref ref-type="bibr" rid="bibr137-0300985811429313">137</xref>
</sup>
</p>
</sec>
<sec id="section10-0300985811429313">
<title>Guinea Pigs</title>
<p>Guinea pigs develop robust DTH responses to mycobacterial antigens and, after infection with Mtb, reproduce many of the aspects of human infection, such as caseous and mineralized granulomas, primary and hematogenous pulmonary lesions, fibrous capsule formation, and dissemination.<sup>
<xref ref-type="bibr" rid="bibr142-0300985811429313">142</xref>
</sup> Cavitation can occur with low-dose, chronic infections of guinea pigs but not as reliably as in the rabbit model.<sup>
<xref ref-type="bibr" rid="bibr221-0300985811429313">221</xref>
</sup> They are also exceptionally vulnerable to infection by as little as a few inhaled mycobacteria, making them well suited for airborne Mtb transmission studies and as sentinel animals.<sup>
<xref ref-type="bibr" rid="bibr175-0300985811429313">175</xref>
</sup>
</p>
<p>Guinea pigs, however, are not suitable for studies of latency because they are very susceptible hosts and often develop chronic progressive disease with extensive tissue destruction after very low-dose aerosol infection.<sup>
<xref ref-type="bibr" rid="bibr189-0300985811429313">189</xref>
</sup> TB is also a primarily hematogenously disseminated disease in the guinea pig.<sup>
<xref ref-type="bibr" rid="bibr189-0300985811429313">189</xref>
</sup> Pulmonary lesions in the guinea pig also contain a high proportion of granulocytes, particularly eosinophils,<sup>
<xref ref-type="bibr" rid="bibr152-0300985811429313">152</xref>
</sup> which are not common features of the human disease. Furthermore, although inbred strains of guinea pigs are available, they are not well characterized with respect to Mtb infection, and immune responsiveness and reagents, although improving, are limited. It is also important to remember that guinea pigs have heterophils, rather than neutrophils, and that heterophils lack myeloperoxidase but instead contain antimicrobial cationic peptides that are not present in human neutrophils.<sup>
<xref ref-type="bibr" rid="bibr125-0300985811429313">125</xref>
</sup> This difference is commonly overlooked by researchers and may be important when interpreting results in these species.</p>
</sec>
<sec id="section11-0300985811429313">
<title>Rabbits</title>
<p>Rabbits infected with Mtb mount a moderate DTH response and form caseous granulomas and cavitary lesions.<sup>
<xref ref-type="bibr" rid="bibr133-0300985811429313">133</xref>
</sup> Rabbits, including currently available inbred strains, are relatively resistant to Mtb, however, requiring the inhalation of 500 to 3000 bacilli to form one grossly visible tubercle at 5 weeks postinfection.<sup>
<xref ref-type="bibr" rid="bibr133-0300985811429313">133</xref>
</sup> Most rabbits will also overcome disease completely, with few culturable bacilli.<sup>
<xref ref-type="bibr" rid="bibr131-0300985811429313">131</xref>
</sup> This model is useful in the study of latent or paucibacillary TB states, however, without the use of antibiotics as in the Cornell model. Rabbits do need to be experimentally immunosuppressed, however, as they will not spontaneously reactivate disease.<sup>
<xref ref-type="bibr" rid="bibr134-0300985811429313">134</xref>
</sup> There are minimal immune reagents, however, for this model, and the larger size of rabbits makes them more costly to use. There are inbred strains of rabbits, such as the Lurie and Thorbecke rabbits, which are more susceptible to Mtb infection. This susceptibility has been linked to suppressed macrophage antimycobacterial activity, decreased MHC class II expression, and impaired development of type IV hypersensitivity.<sup>
<xref ref-type="bibr" rid="bibr131-0300985811429313">131</xref>,<xref ref-type="bibr" rid="bibr145-0300985811429313">145</xref>
</sup> Rabbits, like guinea pigs, also have heterophils as opposed to neutrophils.</p>
</sec>
<sec id="section12-0300985811429313">
<title>Nonhuman Primates</title>
<p>Nonhuman primates, such as the cynomolgus macaque, although expensive and challenging to work with, do provide an excellent model to study TB. Fifty percent of cynomolgus macaques infected via bronchoscope develop primary TB, whereas the other half become latently infected and can reactivate, and the full spectrum of granuloma types can be observed.<sup>
<xref ref-type="bibr" rid="bibr34-0300985811429313">34</xref>
</sup> This model is also important for the study of coinfection with simian immunodeficiency virus and Mtb, as coinfection with HIV is particularly common in sub-Saharan Africa, and TB is the most common cause of death in HIV patients.<sup>
<xref ref-type="bibr" rid="bibr6-0300985811429313">6</xref>
</sup> DTH responses in nonhuman primates are typically weak, with low rates of skin test positivity unless the more potent old tuberculin is used.<sup>
<xref ref-type="bibr" rid="bibr184-0300985811429313">184</xref>
</sup> Although human reagents can often be used for analyses, because of the expense and difficulties of handling nonhuman primates, as well as the lack of inbred strains and potential for horizontal transmission within a colony, this animal model has not been widely used except in industry, as part of vaccine and treatment studies.</p>
</sec>
</sec>
<sec id="section13-0300985811429313">
<title>Conclusion</title>
<p>The tuberculous granuloma can be viewed as either a dance or a battleground between the pathogen and the host that has evolved over millennia. Changes in Mtb and in the granuloma environment can easily tip the scale in favor of one side versus the other. Although a tremendous amount of research has been performed in the study of TB, this disease continues to be a scourge upon humanity and veterinary species. Until the factors affecting each side of this battle are better understood, we are likely to continue to suffer this plague. The continued development of animal models and reagents, as well as the wide use of genetic and other screens to study virulence factors in Mtb, will help us in this endeavor. The veterinary pathologist can play an important role on the front lines, diagnostically, as well as in the interpretation of lesions produced during experimental infection.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>I thank Dr. Elizabeth Rhoades for her help editing the parts of this review that composed the literature review of my dissertation and Drs. Kyle Rohde, Melinda Camus, and Andrew Moorhead for their help in editing this version. Thanks also to Dr. Mi-Jeong Kim for providing the human TB photomicrographs and to Dr. Helen Wainwright and Ms. Annalie Visser at the University of Cape Town, South Africa, for providing Dr. Kim with access to human pulmonary TB lesions. I also thank Dr. David Russell for his guidance and support during my graduate studies. I am grateful to the editors and reviewers of this manuscript, who provided excellent suggestions and constructive criticism. Finally, I would like to recognize and apologize to all of the researchers whose work I could not include in this review due to restrictions in the number of references I could include (my original reference list contained almost 500 citations). This review and my own research could not have happened without the tremendous effort of TB researchers past and present.</p>
</ack>
<fn-group>
<fn fn-type="conflict" id="fn1-0300985811429313">
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure" id="fn2-0300985811429313">
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-0300985811429313">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abebe</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Holm-Hansen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Wiker</surname>
<given-names>HG</given-names>
</name>
<etal/>
</person-group> <article-title>Progress in serodiagnosis of <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Scand J Immunol</source>. <year>2007</year>; <volume>66</volume>: <fpage>176</fpage>–<lpage>191</lpage>.</citation>
</ref>
<ref id="bibr2-0300985811429313">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>DO</given-names>
</name>
</person-group>. <article-title>Molecular interactions in macrophage activation</article-title>. <source>Immunol Today</source>. <year>1989</year>; <volume>10</volume>: <fpage>33</fpage>–<lpage>35</lpage>.</citation>
</ref>
<ref id="bibr3-0300985811429313">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Algood</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Yankura</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source>. <year>2004</year>; <volume>172</volume>: <fpage>6846</fpage>–<lpage>6857</lpage>.</citation>
</ref>
<ref id="bibr4-0300985811429313">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alonso</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pethe</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>DG</given-names>
</name>
<etal/>
</person-group> <article-title>Lysosomal killing of <italic>Mycobacterium</italic> mediated by ubiquitin-derived peptides is enhanced by autophagy</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2007</year>; <volume>104</volume>: <fpage>6031</fpage>–<lpage>6036</lpage>.</citation>
</ref>
<ref id="bibr5-0300985811429313">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aly</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wagner</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Oxygen status of lung granulomas in <italic>Mycobacterium tuberculosis</italic>–infected mice</article-title>. <source>J Pathol</source>. <year>2006</year>; <volume>210</volume>: <fpage>298</fpage>–<lpage>305</lpage>.</citation>
</ref>
<ref id="bibr6-0300985811429313">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anandaiah</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dheda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Keane</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Novel developments in the epidemic of HIV and TB co-infection</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2011</year>; <volume>183</volume>: <fpage>987</fpage>–<lpage>997</lpage>.</citation>
</ref>
<ref id="bibr7-0300985811429313">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armstrong</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hart</surname>
<given-names>PD</given-names>
</name>
</person-group>. <article-title>Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli: reversal of the usual nonfusion pattern and observations on bacterial survival</article-title>. <source>J Exp Med</source>. <year>1975</year>; <volume>142</volume>: <fpage>1</fpage>–<lpage>16</lpage>.</citation>
</ref>
<ref id="bibr8-0300985811429313">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Artman</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bekierkunst</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Goldenberg</surname>
<given-names>I</given-names>
</name>
</person-group>. <article-title>Tissue metabolism in infection: biochemical changes in mice treated with cord factor</article-title>. <source>Arch Biochem Biophys</source>. <year>1964</year>; <volume>105</volume>: <fpage>80</fpage>–<lpage>85</lpage>.</citation>
</ref>
<ref id="bibr9-0300985811429313">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Austin</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Graviss</surname>
<given-names>EA</given-names>
</name>
</person-group>. <article-title>Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African Americans</article-title>. <source>J Infect Dis</source>. <year>2008</year>; <volume>197</volume>: <fpage>1713</fpage>–<lpage>1716</lpage>.</citation>
</ref>
<ref id="bibr10-0300985811429313">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Axelrod</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Oschkinat</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Enders</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide</article-title>. <source>Cell Microbiol</source>. <year>2008</year>; <volume>10</volume>: <fpage>1530</fpage>–<lpage>1545</lpage>.</citation>
</ref>
<ref id="bibr11-0300985811429313">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bafica</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Scanga</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>CG</given-names>
</name>
<etal/>
</person-group> <article-title>TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Exp Med</source>. <year>2005</year>; <volume>202</volume>: <fpage>1715</fpage>–<lpage>1724</lpage>.</citation>
</ref>
<ref id="bibr12-0300985811429313">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balasubramanian</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Wiegeshaus</surname>
<given-names>EH</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>BT</given-names>
</name>
<etal/>
</person-group> <article-title>Pathogenesis of tuberculosis: pathway to apical localization</article-title>. <source>Tuber Lung Dis</source>. <year>1994</year>; <volume>75</volume>: <fpage>168</fpage>–<lpage>178</lpage>.</citation>
</ref>
<ref id="bibr13-0300985811429313">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Banchereau</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Steinman</surname>
<given-names>RM</given-names>
</name>
</person-group>. <article-title>Dendritic cells and the control of immunity</article-title>. <source>Nature</source>. <year>1998</year>; <volume>392</volume>: <fpage>245</fpage>–<lpage>252</lpage>.</citation>
</ref>
<ref id="bibr14-0300985811429313">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barry</surname>
<given-names>CE III</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Mdluli</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Mycolic acids: structure, biosynthesis and physiological functions</article-title>. <source>Prog Lipid Res</source>. <year>1998</year>; <volume>37</volume>: <fpage>143</fpage>–<lpage>179</lpage>.</citation>
</ref>
<ref id="bibr15-0300985811429313">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bates</surname>
<given-names>JH</given-names>
</name>
</person-group>. <article-title>Transmission and pathogenesis of tuberculosis</article-title>. <source>Clin Chest Med</source>. <year>1980</year>; <volume>1</volume>: <fpage>167</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr16-0300985811429313">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beatty</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Rhoades</surname>
<given-names>ER</given-names>
</name>
<name>
<surname>Ullrich</surname>
<given-names>HJ</given-names>
</name>
<etal/>
</person-group> <article-title>Trafficking and release of mycobacterial lipids from infected macrophages</article-title>. <source>Traffic</source>. <year>2000</year>; <volume>1</volume>: <fpage>235</fpage>–<lpage>247</lpage>.</citation>
</ref>
<ref id="bibr17-0300985811429313">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beckman</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Porcelli</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Morita</surname>
<given-names>CT</given-names>
</name>
<etal/>
</person-group> <article-title>Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells</article-title>. <source>Nature</source>. <year>1994</year>; <volume>372</volume>: <fpage>691</fpage>–<lpage>694</lpage>.</citation>
</ref>
<ref id="bibr18-0300985811429313">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behar</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Dascher</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Grusby</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group> <article-title>Susceptibility of mice deficient in CD1D or TAP1 to infection with <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Exp Med</source>. <year>1999</year>; <volume>189</volume>: <fpage>1973</fpage>–<lpage>1980</lpage>.</citation>
</ref>
<ref id="bibr19-0300985811429313">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Behr</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Gill</surname>
<given-names>WP</given-names>
</name>
<etal/>
</person-group> <article-title>Comparative genomics of BCG vaccines by whole-genome DNA microarray</article-title>. <source>Science</source>. <year>1999</year>; <volume>284</volume>: <fpage>1520</fpage>–<lpage>1523</lpage>.</citation>
</ref>
<ref id="bibr20-0300985811429313">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benini</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ehlers</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Ehlers</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Different types of pulmonary granuloma necrosis in immunocompetent vs. TNFRp55-gene-deficient mice aerogenically infected with highly virulent <italic>Mycobacterium avium</italic> </article-title>. <source>J Pathol</source>. <year>1999</year>; <volume>189</volume>: <fpage>127</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr21-0300985811429313">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bermudez</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Petrofsky</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Interleukin-6 antagonizes tumor necrosis factor–mediated mycobacteriostatic and mycobactericidal activities in macrophages</article-title>. <source>Infect Immun</source>. <year>1992</year>; <volume>60</volume>: <fpage>4245</fpage>–<lpage>4252</lpage>.</citation>
</ref>
<ref id="bibr22-0300985811429313">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bertagnolli</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>BY</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>IL-12 augments antigen-dependent proliferation of activated T lymphocytes</article-title>. <source>J Immunol</source>. <year>1992</year>; <volume>149</volume>: <fpage>3778</fpage>–<lpage>3783</lpage>.</citation>
</ref>
<ref id="bibr23-0300985811429313">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berthet</surname>
<given-names>FX</given-names>
</name>
<name>
<surname>Lagranderie</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gounon</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Attenuation of virulence by disruption of the <italic>Mycobacterium tuberculosis</italic> erp gene</article-title>. <source>Science</source>. <year>1998</year>; <volume>282</volume>: <fpage>759</fpage>–<lpage>762</lpage>.</citation>
</ref>
<ref id="bibr24-0300985811429313">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Biedermann</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Mailhammer</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mai</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Reversal of established delayed type hypersensitivity reactions following therapy with IL-4 or antigen-specific Th2 cells</article-title>. <source>Eur J Immunol</source>. <year>2001</year>; <volume>31</volume>: <fpage>1582</fpage>–<lpage>1591</lpage>.</citation>
</ref>
<ref id="bibr25-0300985811429313">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloch</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro</article-title>. <source>J Bacteriol</source>. <year>1956</year>; <volume>72</volume>: <fpage>132</fpage>–<lpage>141</lpage>.</citation>
</ref>
<ref id="bibr26-0300985811429313">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boshoff</surname>
<given-names>HI</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>CE III</given-names>
</name>
</person-group>. <article-title>Tuberculosis: metabolism and respiration in the absence of growth</article-title>. <source>Nat Rev Microbiol</source>. <year>2005</year>; <volume>3</volume>: <fpage>70</fpage>–<lpage>80</lpage>.</citation>
</ref>
<ref id="bibr27-0300985811429313">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowdish</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Sakamoto</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group> <article-title>MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>PLoS Pathog</source>. <year>2009</year>; <volume>5</volume>: <fpage>e1000474</fpage>.</citation>
</ref>
<ref id="bibr28-0300985811429313">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brightbill</surname>
<given-names>HD</given-names>
</name>
<name>
<surname>Libraty</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>Krutzik</surname>
<given-names>SR</given-names>
</name>
<etal/>
</person-group> <article-title>Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors</article-title>. <source>Science</source>. <year>1999</year>; <volume>285</volume>: <fpage>732</fpage>–<lpage>736</lpage>.</citation>
</ref>
<ref id="bibr29-0300985811429313">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brindle</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Nunn</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Githui</surname>
<given-names>W</given-names>
</name>
<etal/>
</person-group> <article-title>Quantitative bacillary response to treatment in HIV-associated pulmonary tuberculosis</article-title>. <source>Am Rev Respir Dis</source>. <year>1993</year>; <volume>147</volume>: <fpage>958</fpage>–<lpage>961</lpage>.</citation>
</ref>
<ref id="bibr30-0300985811429313">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brodin</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Rosenkrands</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>ESAT-6 proteins: protective antigens and virulence factors?</article-title> <source>Trends Microbiol</source>. <year>2004</year>; <volume>12</volume>: <fpage>500</fpage>–<lpage>508</lpage>.</citation>
</ref>
<ref id="bibr31-0300985811429313">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brosch</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Marmiesse</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>A new evolutionary scenario for the <italic>Mycobacterium tuberculosis</italic> complex</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2002</year>; <volume>99</volume>: <fpage>3684</fpage>–<lpage>3689</lpage>.</citation>
</ref>
<ref id="bibr32-0300985811429313">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Calmette</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Boquet</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Negre</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Contribution à l’étude du bacille tuberculeux bilié</article-title>. <source>Ann Inst Pasteur</source>. <year>1921</year>; <volume>35</volume>: <fpage>561</fpage>–<lpage>570</lpage>.</citation>
</ref>
<ref id="bibr33-0300985811429313">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canetti</surname>
<given-names>G</given-names>
</name>
</person-group>. <article-title>Exogenous reinfection and pulmonary tuberculosis a study of the pathology</article-title>. <source>Tubercle</source>. <year>1950</year>; <volume>31</volume>: <fpage>224</fpage>–<lpage>233</lpage>.</citation>
</ref>
<ref id="bibr34-0300985811429313">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capuano</surname>
<given-names>SV III</given-names>
</name>
<name>
<surname>Croix</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Pawar</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Experimental <italic>Mycobacterium tuberculosis</italic> infection of cynomolgus macaques closely resembles the various manifestations of human <italic>M. tuberculosis</italic> infection</article-title>. <source>Infect Immun</source>. <year>2003</year>; <volume>71</volume>: <fpage>5831</fpage>–<lpage>5844</lpage>.</citation>
</ref>
<ref id="bibr35-0300985811429313">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fan</surname>
<given-names>XD</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>SW</given-names>
</name>
<etal/>
</person-group> <article-title>Lipoarabinomannan, a possible virulence factor involved in persistence of <italic>Mycobacterium tuberculosis</italic> within macrophages</article-title>. <source>Infect Immun</source>. <year>1991</year>; <volume>59</volume>: <fpage>1755</fpage>–<lpage>1761</lpage>.</citation>
</ref>
<ref id="bibr36-0300985811429313">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Magliozzo</surname>
<given-names>RS</given-names>
</name>
<etal/>
</person-group> <article-title>Killing of virulent <italic>Mycobacterium tuberculosis</italic> by reactive nitrogen intermediates produced by activated murine macrophages</article-title>. <source>J Exp Med</source>. <year>1992</year>; <volume>175</volume>: <fpage>1111</fpage>–<lpage>1122</lpage>.</citation>
</ref>
<ref id="bibr37-0300985811429313">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Miner</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>AK</given-names>
</name>
<etal/>
</person-group> <article-title>igr Genes and <italic>Mycobacterium tuberculosis</italic> cholesterol metabolism</article-title>. <source>J Bacteriol</source>. <year>2009</year>; <volume>191</volume>: <fpage>5232</fpage>–<lpage>5239</lpage>.</citation>
</ref>
<ref id="bibr38-0300985811429313">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chegou</surname>
<given-names>NN</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Kidd</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report</article-title>. <source>BMC Pulm Med</source>. <year>2009</year>; <volume>9</volume>: <fpage>21</fpage>.</citation>
</ref>
<ref id="bibr39-0300985811429313">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>RC</given-names>
</name>
<etal/>
</person-group> <article-title>A critical role for CD8 T cells in a nonhuman primate model of tuberculosis</article-title>. <source>PLoS Pathog</source>. <year>2009</year>; <volume>5</volume>: <fpage>e1000392</fpage>.</citation>
</ref>
<ref id="bibr40-0300985811429313">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemens</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Horwitz</surname>
<given-names>MA</given-names>
</name>
</person-group>. <article-title>The <italic>Mycobacterium tuberculosis</italic> phagosome interacts with early endosomes and is accessible to exogenously administered transferrin</article-title>. <source>J Exp Med</source>. <year>1996</year>; <volume>184</volume>: <fpage>1349</fpage>–<lpage>1355</lpage>.</citation>
</ref>
<ref id="bibr41-0300985811429313">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Comstock</surname>
<given-names>GW</given-names>
</name>
</person-group>. <article-title>Epidemiology of tuberculosis</article-title>. <source>Am Rev Respir Dis</source>. <year>1982</year>; <volume>125</volume>: <fpage>8</fpage>–<lpage>15</lpage>.</citation>
</ref>
<ref id="bibr42-0300985811429313">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Roberts</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Rhoades</surname>
<given-names>ER</given-names>
</name>
<etal/>
</person-group> <article-title>The role of interleukin-12 in acquired immunity to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunology</source>. <year>1995</year>; <volume>84</volume>: <fpage>423</fpage>–<lpage>432</lpage>.</citation>
</ref>
<ref id="bibr43-0300985811429313">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Segal</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Frank</surname>
<given-names>AA</given-names>
</name>
<etal/>
</person-group> <article-title>Transient loss of resistance to pulmonary tuberculosis in p47(phox–/–) mice</article-title>. <source>Infect Immun</source>. <year>2000</year>; <volume>68</volume>: <fpage>1231</fpage>–<lpage>1234</lpage>.</citation>
</ref>
<ref id="bibr44-0300985811429313">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>D’Souza</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denis</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Scorza</surname>
<given-names>T</given-names>
</name>
<etal/>
</person-group> <article-title>CD4+ T cells contain <italic>Mycobacterium tuberculosis</italic> infection in the absence of CD8+ T cells in mice vaccinated with DNA encoding Ag85A</article-title>. <source>Eur J Immunol</source>. <year>2000</year>; <volume>30</volume>: <fpage>2455</fpage>–<lpage>2459</lpage>.</citation>
</ref>
<ref id="bibr45-0300985811429313">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daffe</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Draper</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>The envelope layers of mycobacteria with reference to their pathogenicity</article-title>. <source>Adv Microb Physiol</source>. <year>1998</year>; <volume>39</volume>: <fpage>131</fpage>–<lpage>203</lpage>.</citation>
</ref>
<ref id="bibr46-0300985811429313">
<label>46</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Dannenberg</surname>
<given-names>AM</given-names>
</name>
</person-group>. <article-title>Pathophysiology: basic aspects</article-title>. In: <person-group person-group-type="editor">
<name>
<surname>Schlossberg</surname>
<given-names>D</given-names>
</name>
</person-group>, ed. <source>Tuberculosis and Nontuberculous Mycobacterial Infections</source>. <edition>4th ed</edition>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>WB Saunders</publisher-name>; <year>1999</year>: <fpage>17</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr47-0300985811429313">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Backer</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Mortele</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>De Keulenaer</surname>
<given-names>BL</given-names>
</name>
<etal/>
</person-group> <article-title>Tuberculosis: epidemiology, manifestations, and the value of medical imaging in diagnosis</article-title>. <source>JBR-BTR</source>. <year>2006</year>; <volume>89</volume>: <fpage>243</fpage>–<lpage>250</lpage>.</citation>
</ref>
<ref id="bibr48-0300985811429313">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Chastellier</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Forquet</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>
<italic>Mycobacterium</italic> requires an all-around closely apposing phagosome membrane to maintain the maturation block and this apposition is re-established when it rescues itself from phagolysosomes</article-title>. <source>Cell Microbiol</source>. <year>2009</year>; <volume>11</volume>: <fpage>1190</fpage>–<lpage>1207</lpage>.</citation>
</ref>
<ref id="bibr49-0300985811429313">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Valliere</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Abate</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Blazevic</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Enhancement of innate and cell-mediated immunity by antimycobacterial antibodies</article-title>. <source>Infect Immun</source>. <year>2005</year>; <volume>73</volume>: <fpage>6711</fpage>–<lpage>6720</lpage>.</citation>
</ref>
<ref id="bibr50-0300985811429313">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delgado</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Elmaoued</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>AS</given-names>
</name>
<etal/>
</person-group> <article-title>Toll-like receptors control autophagy</article-title>. <source>EMBO J</source>. <year>2008</year>; <volume>27</volume>: <fpage>1110</fpage>–<lpage>1121</lpage>.</citation>
</ref>
<ref id="bibr51-0300985811429313">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denis</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Human neutrophils, activated with cytokines or not, do not kill virulent <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Infect Dis</source>. <year>1991</year>; <volume>163</volume>: <fpage>919</fpage>–<lpage>920</lpage>.</citation>
</ref>
<ref id="bibr52-0300985811429313">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denis</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gregg</surname>
<given-names>EO</given-names>
</name>
</person-group>. <article-title>Recombinant interleukin-6 increases the intracellular and extracellular growth of <italic>Mycobacterium avium</italic> </article-title>. <source>Can J Microbiol</source>. <year>1991</year>; <volume>37</volume>: <fpage>479</fpage>–<lpage>483</lpage>.</citation>
</ref>
<ref id="bibr53-0300985811429313">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Derrick</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>SL</given-names>
</name>
</person-group>. <article-title>The ESAT6 protein of <italic>Mycobacterium tuberculosis</italic> induces apoptosis of macrophages by activating caspase expression</article-title>. <source>Cell Microbiol</source>. <year>2007</year>; <volume>9</volume>: <fpage>1547</fpage>–<lpage>1555</lpage>.</citation>
</ref>
<ref id="bibr54-0300985811429313">
<label>54</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Diamond</surname>
<given-names>JM</given-names>
</name>
</person-group>. <source>Guns, Germs, and Steel: The Fates of Human Societies</source>. <publisher-loc>New York</publisher-loc>: <publisher-name>W. W. Norton</publisher-name>; <year>1997</year>.</citation>
</ref>
<ref id="bibr55-0300985811429313">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Divangahi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mostowy</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Coulombe</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>NOD2-deficient mice have impaired resistance to <italic>Mycobacterium tuberculosis</italic> infection through defective innate and adaptive immunity</article-title>. <source>J Immunol</source>. <year>2008</year>; <volume>181</volume>: <fpage>7157</fpage>–<lpage>7165</lpage>.</citation>
</ref>
<ref id="bibr56-0300985811429313">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diveu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>McGeachy</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Cua</surname>
<given-names>DJ</given-names>
</name>
</person-group>. <article-title>Cytokines that regulate autoimmunity</article-title>. <source>Curr Opin Immunol</source>. <year>2008</year>; <volume>20</volume>: <fpage>663</fpage>–<lpage>668</lpage>.</citation>
</ref>
<ref id="bibr57-0300985811429313">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname>
<given-names>C</given-names>
</name>
</person-group>. <article-title>Regulation and pro-inflammatory function of interleukin-17 family cytokines</article-title>. <source>Immunol Rev</source>. <year>2008</year>; <volume>226</volume>: <fpage>80</fpage>–<lpage>86</lpage>.</citation>
</ref>
<ref id="bibr58-0300985811429313">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorman</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>SM</given-names>
</name>
</person-group>. <article-title>Interferon-gamma and interleukin-12 pathway defects and human disease</article-title>. <source>Cytokine Growth Factor Rev</source>. <year>2000</year>; <volume>11</volume>: <fpage>321</fpage>–<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr59-0300985811429313">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dussurget</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Neyrolles</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group> <article-title>Role of <italic>Mycobacterium tuberculosis</italic> copper-zinc superoxide dismutase</article-title>. <source>Infect Immun</source>. <year>2001</year>; <volume>69</volume>: <fpage>529</fpage>–<lpage>533</lpage>.</citation>
</ref>
<ref id="bibr60-0300985811429313">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ernst</surname>
<given-names>JD</given-names>
</name>
</person-group>. <article-title>Macrophage receptors for <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>Infect Immun</source>. <year>1998</year>; <volume>66</volume>: <fpage>1277</fpage>–<lpage>1281</lpage>.</citation>
</ref>
<ref id="bibr61-0300985811429313">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eruslanov</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Lyadova</surname>
<given-names>IV</given-names>
</name>
<name>
<surname>Kondratieva</surname>
<given-names>TK</given-names>
</name>
<etal/>
</person-group> <article-title>Neutrophil responses to <italic>Mycobacterium tuberculosis </italic>infection in genetically susceptible and resistant mice</article-title>. <source>Infect Immun</source>. <year>2005</year>; <volume>73</volume>: <fpage>1744</fpage>–<lpage>1753</lpage>.</citation>
</ref>
<ref id="bibr62-0300985811429313">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eum</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>MS</given-names>
</name>
<etal/>
</person-group> <article-title>Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB</article-title>. <source>Chest</source>. <year>2010</year>; <volume>137</volume>: <fpage>122</fpage>–<lpage>128</lpage>.</citation>
</ref>
<ref id="bibr63-0300985811429313">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fantuzzi</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Dinarello</surname>
<given-names>CA</given-names>
</name>
</person-group>. <article-title>The inflammatory response in interleukin-1 beta-deficient mice: comparison with other cytokine-related knock-out mice</article-title>. <source>J Leukoc Biol</source>. <year>1996</year>; <volume>59</volume>: <fpage>489</fpage>–<lpage>493</lpage>.</citation>
</ref>
<ref id="bibr64-0300985811429313">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fenhalls</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bezuidenhout</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas</article-title>. <source>Infect Immun</source>. <year>2000</year>; <volume>68</volume>: <fpage>2827</fpage>–<lpage>2836</lpage>.</citation>
</ref>
<ref id="bibr65-0300985811429313">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrari</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Langen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Naito</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>A coat protein on phagosomes involved in the intracellular survival of mycobacteria</article-title>. <source>Cell</source>. <year>1999</year>; <volume>97</volume>: <fpage>435</fpage>–<lpage>447</lpage>.</citation>
</ref>
<ref id="bibr66-0300985811429313">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filipe-Santos</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Bustamante</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Haverkamp</surname>
<given-names>MH</given-names>
</name>
<etal/>
</person-group> <article-title>X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production</article-title>. <source>J Exp Med</source>. <year>2006</year>; <volume>203</volume>: <fpage>1745</fpage>–<lpage>1759</lpage>.</citation>
</ref>
<ref id="bibr67-0300985811429313">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fine</surname>
<given-names>PE</given-names>
</name>
</person-group>. <article-title>Variation in protection by BCG: implications of and for heterologous immunity</article-title>. <source>Lancet</source>. <year>1995</year>; <volume>346</volume>: <fpage>1339</fpage>–<lpage>1345</lpage>.</citation>
</ref>
<ref id="bibr68-0300985811429313">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Scotet</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Niemeyer</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2004</year>; <volume>101</volume>: <fpage>10685</fpage>–<lpage>10690</lpage>.</citation>
</ref>
<ref id="bibr69-0300985811429313">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Florido</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Appelberg</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Immunological basis of the development of necrotic lesions following <italic>Mycobacterium avium</italic> infection</article-title>. <source>Immunology</source>. <year>2002</year>; <volume>106</volume>: <fpage>590</fpage>–<lpage>601</lpage>.</citation>
</ref>
<ref id="bibr70-0300985811429313">
<label>70</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Floyd</surname>
<given-names>K</given-names>
</name>
</person-group>. <source>Global Tuberculosis Control</source>. <publisher-loc>Geneva, Switzerland</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2009</year>.</citation>
</ref>
<ref id="bibr71-0300985811429313">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flynn</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Triebold</surname>
<given-names>KJ</given-names>
</name>
<etal/>
</person-group> <article-title>An essential role for interferon gamma in resistance to <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Exp Med</source>. <year>1993</year>; <volume>178</volume>: <fpage>2249</fpage>–<lpage>2254</lpage>.</citation>
</ref>
<ref id="bibr72-0300985811429313">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flynn</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Goldstein</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Tumor necrosis factor–alpha is required in the protective immune response against <italic>Mycobacterium tuberculosis</italic> in mice</article-title>. <source>Immunity</source>. <year>1995</year>; <volume>2</volume>: <fpage>561</fpage>–<lpage>572</lpage>.</citation>
</ref>
<ref id="bibr73-0300985811429313">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Flynn</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Scanga</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>KE</given-names>
</name>
<etal/>
</person-group> <article-title>Effects of aminoguanidine on latent murine tuberculosis</article-title>. <source>J Immunol</source>. <year>1998</year>; <volume>160</volume>: <fpage>1796</fpage>–<lpage>1803</lpage>.</citation>
</ref>
<ref id="bibr74-0300985811429313">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forbes</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Gros</surname>
<given-names>P</given-names>
</name>
</person-group>. <article-title>Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane</article-title>. <source>Blood</source>. <year>2003</year>; <volume>102</volume>: <fpage>1884</fpage>–<lpage>1892</lpage>.</citation>
</ref>
<ref id="bibr75-0300985811429313">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fratti</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Backer</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Gruenberg</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest</article-title>. <source>J Cell Biol</source>. <year>2001</year>; <volume>154</volume>: <fpage>631</fpage>–<lpage>644</lpage>.</citation>
</ref>
<ref id="bibr76-0300985811429313">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fratti</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vergne</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group> <article-title>
<italic>Mycobacterium tuberculosis</italic> glycosylated phosphatidylinositol causes phagosome maturation arrest</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2003</year>; <volume>100</volume>: <fpage>5437</fpage>–<lpage>5442</lpage>.</citation>
</ref>
<ref id="bibr77-0300985811429313">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fremond</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Yeremeev</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Nicolle</surname>
<given-names>DM</given-names>
</name>
<etal/>
</person-group> <article-title>Fatal <italic>Mycobacterium tuberculosis</italic> infection despite adaptive immune response in the absence of MyD88</article-title>. <source>J Clin Invest</source>. <year>2004</year>; <volume>114</volume>: <fpage>1790</fpage>–<lpage>1799</lpage>.</citation>
</ref>
<ref id="bibr78-0300985811429313">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fulton</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Reba</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>TD</given-names>
</name>
<etal/>
</person-group> <article-title>Neutrophil-mediated mycobacteriocidal immunity in the lung during <italic>Mycobacterium bovis</italic> BCG infection in C57BL/6 mice</article-title>. <source>Infect Immun</source>. <year>2002</year>; <volume>70</volume>: <fpage>5322</fpage>–<lpage>5327</lpage>.</citation>
</ref>
<ref id="bibr79-0300985811429313">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>He</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>Enhancement of antimycobacterial activity of macrophages by stabilization of inner mitochondrial membrane potential</article-title>. <source>J Infect Dis</source>. <year>2005</year>; <volume>191</volume>: <fpage>1292</fpage>–<lpage>1300</lpage>.</citation>
</ref>
<ref id="bibr80-0300985811429313">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ganguly</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Giang</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>
<italic>Mycobacterium tuberculosis</italic> secretory proteins CFP-10, ESAT-6 and the CFP10: ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production</article-title>. <source>Immunol Cell Biol</source>. <year>2008</year>; <volume>86</volume>: <fpage>98</fpage>–<lpage>106</lpage>.</citation>
</ref>
<ref id="bibr81-0300985811429313">
<label>81</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Garay</surname>
<given-names>S</given-names>
</name>
</person-group>. <source>Pulmonary Tuberculosis</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Little, Brown</publisher-name>; <year>1996</year>.</citation>
</ref>
<ref id="bibr82-0300985811429313">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Perez</surname>
<given-names>BE</given-names>
</name>
<name>
<surname>Mondragon-Flores</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Luna-Herrera</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Internalization of <italic>Mycobacterium tuberculosis</italic> by macropinocytosis in non-phagocytic cells</article-title>. <source>Microb Pathog</source>. <year>2003</year>; <volume>35</volume>: <fpage>49</fpage>–<lpage>55</lpage>.</citation>
</ref>
<ref id="bibr83-0300985811429313">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Guler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vesin</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Lethal <italic>Mycobacterium bovis</italic> Bacillus Calmette Guerin infection in nitric oxide synthase 2–deficient mice: cell-mediated immunity requires nitric oxide synthase 2</article-title>. <source>Lab Invest</source>. <year>2000</year>; <volume>80</volume>: <fpage>1385</fpage>–<lpage>1397</lpage>.</citation>
</ref>
<ref id="bibr84-0300985811429313">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geijtenbeek</surname>
<given-names>TB</given-names>
</name>
<name>
<surname>Van Vliet</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Koppel</surname>
<given-names>EA</given-names>
</name>
<etal/>
</person-group> <article-title>Mycobacteria target DC-SIGN to suppress dendritic cell function</article-title>. <source>J Exp Med</source>. <year>2003</year>; <volume>197</volume>: <fpage>7</fpage>–<lpage>17</lpage>.</citation>
</ref>
<ref id="bibr85-0300985811429313">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gerosa</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Baldani-Guerra</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lyakh</surname>
<given-names>LA</given-names>
</name>
<etal/>
</person-group> <article-title>Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells</article-title>. <source>J Exp Med</source>. <year>2008</year>; <volume>205</volume>: <fpage>1447</fpage>–<lpage>1461</lpage>.</citation>
</ref>
<ref id="bibr86-0300985811429313">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilleron</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Stenger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Mazorra</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Exp Med</source>. <year>2004</year>; <volume>199</volume>: <fpage>649</fpage>–<lpage>659</lpage>.</citation>
</ref>
<ref id="bibr87-0300985811429313">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gruenheid</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Pinner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Desjardins</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Natural resistance to infection with intracellular pathogens: the Nramp1 protein is recruited to the membrane of the phagosome</article-title>. <source>J Exp Med</source>. <year>1997</year>; <volume>185</volume>: <fpage>717</fpage>–<lpage>730</lpage>.</citation>
</ref>
<ref id="bibr88-0300985811429313">
<label> 88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guirado</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Amat</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gil</surname>
<given-names>O</given-names>
</name>
<etal/>
</person-group> <article-title>Passive serum therapy with polyclonal antibodies against <italic>Mycobacterium tuberculosis</italic> protects against post-chemotherapy relapse of tuberculosis infection in SCID mice</article-title>. <source>Microbes Infect</source>. <year>2006</year>; <volume>8</volume>: <fpage>1252</fpage>–<lpage>1259</lpage>.</citation>
</ref>
<ref id="bibr89-0300985811429313">
<label> 89</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gumperz</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Brenner</surname>
<given-names>MB</given-names>
</name>
</person-group>. <article-title>CD1-specific T cells in microbial immunity</article-title>. <source>Curr Opin Immunol</source>. <year>2001</year>; <volume>13</volume>: <fpage>471</fpage>–<lpage>478</lpage>.</citation>
</ref>
<ref id="bibr90-0300985811429313">
<label> 90</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutierrez</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Brisse</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Brosch</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Ancient origin and gene mosaicism of the progenitor of <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>PLoS Pathog</source>. <year>2005</year>; <volume>1</volume>: <fpage>e5</fpage>.</citation>
</ref>
<ref id="bibr91-0300985811429313">
<label> 91</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gutierrez</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Master</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>SB</given-names>
</name>
<etal/>
</person-group> <article-title>Autophagy is a defense mechanism inhibiting BCG and <italic>Mycobacterium tuberculosis</italic> survival in infected macrophages</article-title>. <source>Cell</source>. <year>2004</year>; <volume>119</volume>: <fpage>753</fpage>–<lpage>766</lpage>.</citation>
</ref>
<ref id="bibr92-0300985811429313">
<label> 92</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guyot-Revol</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Innes</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Hackforth</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2006</year>; <volume>173</volume>: <fpage>803</fpage>–<lpage>810</lpage>.</citation>
</ref>
<ref id="bibr93-0300985811429313">
<label> 93</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamasur</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Haile</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Pawlowski</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>A mycobacterial lipoarabinomannan specific monoclonal antibody and its F(ab’) fragment prolong survival of mice infected with <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>Clin Exp Immunol</source>. <year>2004</year>; <volume>138</volume>: <fpage>30</fpage>–<lpage>38</lpage>.</citation>
</ref>
<ref id="bibr94-0300985811429313">
<label> 94</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>He</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Oka</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Relationships between structure and biological activity of the mycolic acid–containing glycolipids from <italic>Nocardia asteroides</italic> “sensu stricto” and related species</article-title>. <source>Acta Leprol</source>. <year>1989</year>; <volume>7</volume>(<issue>suppl 1</issue>): <fpage>130</fpage>–<lpage>132</lpage>.</citation>
</ref>
<ref id="bibr95-0300985811429313">
<label> 95</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>J</given-names>
</name>
<name>
<surname>De Haro</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Master</surname>
<given-names>SS</given-names>
</name>
<etal/>
</person-group> <article-title>T helper 2 cytokines inhibit autophagic control of intracellular <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>Immunity</source>. <year>2007</year>; <volume>27</volume>: <fpage>505</fpage>–<lpage>517</lpage>.</citation>
</ref>
<ref id="bibr96-0300985811429313">
<label> 96</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harshey</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Ramakrishnan</surname>
<given-names>T</given-names>
</name>
</person-group>. <article-title>Rate of ribonucleic acid chain growth in <italic>Mycobacterium tuberculosis</italic> H37Rv</article-title>. <source>J Bacteriol</source>. <year>1977</year>; <volume>129</volume>: <fpage>616</fpage>–<lpage>622</lpage>.</citation>
</ref>
<ref id="bibr97-0300985811429313">
<label> 97</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez-Pando</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Aguilar</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hernandez</surname>
<given-names>ML</given-names>
</name>
<etal/>
</person-group> <article-title>Pulmonary tuberculosis in BALB/c mice with non-functional IL-4 genes: changes in the inflammatory effects of TNF-alpha and in the regulation of fibrosis</article-title>. <source>Eur J Immunol</source>. <year>2004</year>; <volume>34</volume>: <fpage>174</fpage>–<lpage>183</lpage>.</citation>
</ref>
<ref id="bibr98-0300985811429313">
<label> 98</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez-Pando</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jeyanathan</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mengistu</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Persistence of DNA from <italic>Mycobacterium tuberculosis</italic> in superficially normal lung tissue during latent infection</article-title>. <source>Lancet</source>. <year>2000</year>; <volume>356</volume>: <fpage>2133</fpage>–<lpage>2138</lpage>.</citation>
</ref>
<ref id="bibr99-0300985811429313">
<label> 99</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hernandez-Pando</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pavon</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Arriaga</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Pathogenesis of tuberculosis in mice exposed to low and high doses of an environmental mycobacterial saprophyte before infection</article-title>. <source>Infect Immun</source>. <year>1997</year>; <volume>65</volume>: <fpage>3317</fpage>–<lpage>3327</lpage>.</citation>
</ref>
<ref id="bibr100-0300985811429313">
<label>100</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirsch</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Toossi</surname>
<given-names>Z</given-names>
</name>
<etal/>
</person-group> <article-title>Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1996</year>; <volume>93</volume>: <fpage>3193</fpage>–<lpage>3198</lpage>.</citation>
</ref>
<ref id="bibr101-0300985811429313">
<label>101</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hmama</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sendide</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Talal</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway</article-title>. <source>J Cell Sci</source>. <year>2004</year>; <volume>117</volume>: <fpage>2131</fpage>–<lpage>2140</lpage>.</citation>
</ref>
<ref id="bibr102-0300985811429313">
<label>102</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoff</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Driver</surname>
<given-names>ER</given-names>
</name>
<etal/>
</person-group> <article-title>Location of intra- and extracellular <italic>M. tuberculosis</italic> populations in lungs of mice and guinea pigs during disease progression and after drug treatment</article-title>. <source>PLoS One</source>. <year>20111</year>; <volume>6</volume>: <fpage>e17550</fpage>.</citation>
</ref>
<ref id="bibr103-0300985811429313">
<label>103</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holland</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Eisenstein</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Kuhns</surname>
<given-names>DB</given-names>
</name>
<etal/>
</person-group> <article-title>Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon gamma: a preliminary report</article-title>. <source>N Engl</source> <source>J Med</source>. <year>1994</year>; <volume>330</volume>: <fpage>1348</fpage>–<lpage>1355</lpage>.</citation>
</ref>
<ref id="bibr104-0300985811429313">
<label>104</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hsu</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hingley-Wilson</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>The primary mechanism of attenuation of bacillus Calmette-Guerin is a loss of secreted lytic function required for invasion of lung interstitial tissue</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2003</year>; <volume>100</volume>: <fpage>12420</fpage>–<lpage>12425</lpage>.</citation>
</ref>
<ref id="bibr105-0300985811429313">
<label>105</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hughes</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Skuce</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Doig</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Analysis of multidrug-resistant <italic>Mycobacterium bovis</italic> from three clinical samples from Scotland</article-title>. <source>Int J Tuberc Lung Dis</source>. <year>2003</year>; <volume>7</volume>: <fpage>1191</fpage>–<lpage>1198</lpage>.</citation>
</ref>
<ref id="bibr106-0300985811429313">
<label>106</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hunter</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jagannath</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Trehalose 6,6′-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice</article-title>. <source>Am J Pathol</source>. <year>2006</year>; <volume>168</volume>: <fpage>1249</fpage>–<lpage>1261</lpage>.</citation>
</ref>
<ref id="bibr107-0300985811429313">
<label>107</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Means</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Heldwein</surname>
<given-names>KA</given-names>
</name>
<etal/>
</person-group> <article-title>Different Toll-like receptor agonists induce distinct macrophage responses</article-title>. <source>J Leukoc Biol</source>. <year>2001</year>; <volume>69</volume>: <fpage>1036</fpage>–<lpage>1044</lpage>.</citation>
</ref>
<ref id="bibr108-0300985811429313">
<label>108</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Amirault</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>BR</given-names>
</name>
</person-group>. <article-title>Killing of <italic>Mycobacterium tuberculosis </italic>by neutrophils: a nonoxidative process</article-title>. <source>J Infect Dis</source>. <year>1990</year>; <volume>162</volume>: <fpage>700</fpage>–<lpage>704</lpage>.</citation>
</ref>
<ref id="bibr109-0300985811429313">
<label>109</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaku</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kawamura</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Uchiyama</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>RD1 region in mycobacterial genome is involved in the induction of necrosis in infected RAW264 cells via mitochondrial membrane damage and ATP depletion</article-title>. <source>FEMS Microbiol Lett</source>. <year>2007</year>; <volume>274</volume>: <fpage>189</fpage>–<lpage>195</lpage>.</citation>
</ref>
<ref id="bibr110-0300985811429313">
<label>110</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kamijo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Shapiro</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide</article-title>. <source>J Exp Med</source>. <year>1993</year>; <volume>178</volume>: <fpage>1435</fpage>–<lpage>1440</lpage>.</citation>
</ref>
<ref id="bibr111-0300985811429313">
<label>111</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname>
<given-names>PB</given-names>
</name>
<name>
<surname>Azad</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Torrelles</surname>
<given-names>JB</given-names>
</name>
<etal/>
</person-group> <article-title>The human macrophage mannose receptor directs <italic>Mycobacterium tuberculosis</italic> lipoarabinomannan-mediated phagosome biogenesis</article-title>. <source>J Exp Med</source>. <year>2005</year>; <volume>202</volume>: <fpage>987</fpage>–<lpage>999</lpage>.</citation>
</ref>
<ref id="bibr112-0300985811429313">
<label>112</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaplan</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Post</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>AL</given-names>
</name>
<etal/>
</person-group> <article-title>
<italic>Mycobacterium tuberculosis</italic> growth at the cavity surface: a microenvironment with failed immunity</article-title>. <source>Infect Immun</source>. <year>2003</year>; <volume>71</volume>: <fpage>7099</fpage>–<lpage>7108</lpage>.</citation>
</ref>
<ref id="bibr113-0300985811429313">
<label>113</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karlsson</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Sant’Ambrogio</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Widdicombe</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>Afferent neural pathways in cough and reflex bronchoconstriction</article-title>. <source>J Appl Physiol</source>. <year>1988</year>; <volume>65</volume>: <fpage>1007</fpage>–<lpage>1023</lpage>.</citation>
</ref>
<ref id="bibr114-0300985811429313">
<label>114</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
</person-group>. <article-title>Site II–specific inhibition of mitochondria oxidative phosphorylation by trehalose-6,6′-dimycolate (cord factor) of <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>Arch Biochem Biophys</source>. <year>1970</year>; <volume>140</volume>: <fpage>379</fpage>–<lpage>390</lpage>.</citation>
</ref>
<ref id="bibr115-0300985811429313">
<label>115</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufmann</surname>
<given-names>SH</given-names>
</name>
</person-group>. <article-title>How can immunology contribute to the control of tuberculosis?</article-title> <source>Nat Rev Immunol</source>. <year>2001</year>; <volume>1</volume>: <fpage>20</fpage>–<lpage>30</lpage>.</citation>
</ref>
<ref id="bibr116-0300985811429313">
<label>116</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keller</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Genetically determined susceptibility to tuberculosis in mice causally involves accelerated and enhanced recruitment of granulocytes</article-title>. <source>Infect Immun</source>. <year>2006</year>; <volume>74</volume>: <fpage>4295</fpage>–<lpage>4309</lpage>.</citation>
</ref>
<ref id="bibr117-0300985811429313">
<label>117</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Wainwright</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Locketz</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism</article-title>. <source>EMBO Mol Med</source>. <year>2010</year>; <volume>2</volume>: <fpage>258</fpage>–<lpage>274</lpage>.</citation>
</ref>
<ref id="bibr118-0300985811429313">
<label>118</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kinhikar</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Verma</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chandra</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Potential role for ESAT6 in dissemination of <italic>M. tuberculosis</italic> via human lung epithelial cells</article-title>. <source>Mol Microbiol</source>. <year>2010</year>; <volume>75</volume>: <fpage>92</fpage>–<lpage>106</lpage>.</citation>
</ref>
<ref id="bibr119-0300985811429313">
<label>119</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koch</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>die aetiologie der tuberculose, a translation by Berna Pinner and Max Pinner with an introduction by Allen K. Krause</article-title>. <source>Am Rev Tuberc</source>. <year>1932</year>; <volume>25</volume>: <fpage>285</fpage>–<lpage>323</lpage>.</citation>
</ref>
<ref id="bibr120-0300985811429313">
<label>120</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krause</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Tuberculosis and public health</article-title>. <source>Am Rev Tuberc</source>. <year>1928</year>; <volume>18</volume>: <fpage>271</fpage>–<lpage>322</lpage>.</citation>
</ref>
<ref id="bibr121-0300985811429313">
<label>121</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ku</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Dupuis-Girod</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dittrich</surname>
<given-names>AM</given-names>
</name>
<etal/>
</person-group> <article-title>NEMO mutations in 2 unrelated boys with severe infections and conical teeth</article-title>. <source>Pediatrics</source>. <year>2005</year>; <volume>115</volume>: <fpage>e615</fpage>–<lpage>619</lpage>.</citation>
</ref>
<ref id="bibr122-0300985811429313">
<label>122</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laneelle</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Tocanne</surname>
<given-names>JF</given-names>
</name>
</person-group>. <article-title>Evidence for penetration in liposomes and in mitochondrial membranes of a fluorescent analogue of cord factor</article-title>. <source>Eur J Biochem</source>. <year>1980</year>; <volume>109</volume>: <fpage>177</fpage>–<lpage>182</lpage>.</citation>
</ref>
<ref id="bibr123-0300985811429313">
<label>123</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Launois</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Blum</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dieye</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Phenolic glycolipid-1 from <italic>M. leprae</italic> inhibits oxygen free radical production by human mononuclear cells</article-title>. <source>Res Immunol</source>. <year>1989</year>; <volume>140</volume>: <fpage>847</fpage>–<lpage>855</lpage>.</citation>
</ref>
<ref id="bibr124-0300985811429313">
<label>124</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Law</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Jagirdar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weiden</surname>
<given-names>MD</given-names>
</name>
<etal/>
</person-group> <article-title>Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung</article-title>. <source>Am J Respir Crit Care Med</source>. <year>1996</year>; <volume>153</volume>: <fpage>1377</fpage>–<lpage>1384</lpage>.</citation>
</ref>
<ref id="bibr125-0300985811429313">
<label>125</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lehrer</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Ladra</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Hake</surname>
<given-names>RB</given-names>
</name>
</person-group>. <article-title>Nonoxidative fungicidal mechanisms of mammalian granulocytes: demonstration of components with candidacidal activity in human, rabbit, and guinea pig leukocytes</article-title>. <source>Infect Immun</source>. <year>1975</year>; <volume>11</volume>: <fpage>1226</fpage>–<lpage>1234</lpage>.</citation>
</ref>
<ref id="bibr126-0300985811429313">
<label>126</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lenaerts</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Hoff</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Aly</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Location of persisting mycobacteria in a guinea pig model of tuberculosis revealed by r207910</article-title>. <source>Antimicrob Agents Chemother</source>. <year>2007</year>; <volume>51</volume>: <fpage>3338</fpage>–<lpage>3345</lpage>.</citation>
</ref>
<ref id="bibr127-0300985811429313">
<label>127</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Levine</surname>
<given-names>ER</given-names>
</name>
</person-group>. <source>Classification of Reinfection Pulmonary Tuberculosis</source>. <publisher-loc>Springfield, IL</publisher-loc>: <publisher-name>Charles C Thomas</publisher-name>; <year>1949</year>.</citation>
</ref>
<ref id="bibr128-0300985811429313">
<label>128</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lissner</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Weinstein</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>O’Brien</surname>
<given-names>AD</given-names>
</name>
</person-group>. <article-title>Mouse chromosome 1 Ity locus regulates microbicidal activity of isolated peritoneal macrophages against a diverse group of intracellular and extracellular bacteria</article-title>. <source>J Immunol</source>. <year>1985</year>; <volume>135</volume>: <fpage>544</fpage>–<lpage>547</lpage>.</citation>
</ref>
<ref id="bibr129-0300985811429313">
<label>129</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lockhart</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Flynn</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>J Immunol</source>. <year>2006</year>; <volume>177</volume>: <fpage>4662</fpage>–<lpage>4669</lpage>.</citation>
</ref>
<ref id="bibr130-0300985811429313">
<label>130</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lopez</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yero</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Falero-Diaz</surname>
<given-names>G</given-names>
</name>
<etal/>
</person-group> <article-title>Induction of a protective response with an IgA monoclonal antibody against <italic>Mycobacterium tuberculosis</italic> 16kDa protein in a model of progressive pulmonary infection</article-title>. <source>Int J Med Microbiol</source>. <year>2009</year>; <volume>299</volume>: <fpage>447</fpage>–<lpage>452</lpage>.</citation>
</ref>
<ref id="bibr131-0300985811429313">
<label>131</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lurie</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Abramson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Heppleston</surname>
<given-names>AG</given-names>
</name>
</person-group>. <article-title>On the response of genetically resistant and susceptible rabbits to the quantitative inhalation of human type tubercle bacilli and the nature of resistance to tuberculosis</article-title>. <source>J Exp Med</source>. <year>1952</year>; <volume>95</volume>: <fpage>119</fpage>–<lpage>134</lpage>.</citation>
</ref>
<ref id="bibr132-0300985811429313">
<label>132</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Maglione</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J</given-names>
</name>
</person-group>. <article-title>B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Immunol</source>. <year>2007</year>; <volume>178</volume>: <fpage>7222</fpage>–<lpage>7234</lpage>.</citation>
</ref>
<ref id="bibr133-0300985811429313">
<label>133</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manabe</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Dannenberg</surname>
<given-names>AM</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Tyagi</surname>
<given-names>SK</given-names>
</name>
<etal/>
</person-group> <article-title>Different strains of <italic>Mycobacterium tuberculosis</italic> cause various spectrums of disease in the rabbit model of tuberculosis</article-title>. <source>Infect Immun</source>. <year>2003</year>; <volume>71</volume>: <fpage>6004</fpage>–<lpage>6011</lpage>.</citation>
</ref>
<ref id="bibr134-0300985811429313">
<label>134</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manabe</surname>
<given-names>YC</given-names>
</name>
<name>
<surname>Kesavan</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Lopez-Molina</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>The aerosol rabbit model of TB latency, reactivation and immune reconstitution inflammatory syndrome</article-title>. <source>Tuberculosis (Edinb)</source>. <year>2008</year>; <volume>88</volume>: <fpage>187</fpage>–<lpage>196</lpage>.</citation>
</ref>
<ref id="bibr135-0300985811429313">
<label>135</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Manca</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Barry</surname>
<given-names>CE III</given-names>
</name>
<etal/>
</person-group> <article-title>
<italic>Mycobacterium tuberculosis</italic> catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro</article-title>. <source>Infect Immun</source>. <year>1999</year>; <volume>67</volume>: <fpage>74</fpage>–<lpage>79</lpage>.</citation>
</ref>
<ref id="bibr136-0300985811429313">
<label>136</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martinez</surname>
<given-names>FO</given-names>
</name>
<name>
<surname>Helming</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Alternative activation of macrophages: an immunologic functional perspective</article-title>. <source>Annu Rev Immunol</source>. <year>2009</year>; <volume>27</volume>: <fpage>451</fpage>–<lpage>483</lpage>.</citation>
</ref>
<ref id="bibr137-0300985811429313">
<label>137</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCune</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Feldmann</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Lambert</surname>
<given-names>HP</given-names>
</name>
<etal/>
</person-group> <article-title>Microbial persistence, I: the capacity of tubercle bacilli to survive sterilization in mouse tissues</article-title>. <source>J Exp Med</source>. <year>1966</year>; <volume>123</volume>: <fpage>445</fpage>–<lpage>468</lpage>.</citation>
</ref>
<ref id="bibr138-0300985811429313">
<label>138</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCune</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Feldmann</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>McDermott</surname>
<given-names>W</given-names>
</name>
</person-group>. <article-title>Microbial persistence, II: characteristics of the sterile state of tubercle bacilli</article-title>. <source>J Exp Med</source>. <year>1966</year>; <volume>123</volume>: <fpage>469</fpage>–<lpage>486</lpage>.</citation>
</ref>
<ref id="bibr139-0300985811429313">
<label>139</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDonough</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Kress</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>Cytotoxicity for lung epithelial cells is a virulence-associated phenotype of <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>Infect Immun</source>. <year>1995</year>; <volume>63</volume>: <fpage>4802</fpage>–<lpage>4811</lpage>.</citation>
</ref>
<ref id="bibr140-0300985811429313">
<label>140</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McKinney</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Honer zu Bentrup</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Munoz-Elias</surname>
<given-names>EJ</given-names>
</name>
<etal/>
</person-group> <article-title>Persistence of <italic>Mycobacterium tuberculosis</italic> in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase</article-title>. <source>Nature</source>. <year>2000</year>; <volume>406</volume>: <fpage>735</fpage>–<lpage>738</lpage>.</citation>
</ref>
<ref id="bibr141-0300985811429313">
<label>141</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McMurray</surname>
<given-names>DN</given-names>
</name>
</person-group>. <article-title>Disease model: pulmonary tuberculosis</article-title>. <source>Trends Mol Med</source>. <year>2001</year>; <volume>7</volume>: <fpage>135</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr142-0300985811429313">
<label>142</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>McMurray</surname>
<given-names>DN</given-names>
</name>
</person-group>. <source>Guinea Pig Model of Tuberculosis</source>. <publisher-loc>Washington, DC</publisher-loc>: <publisher-name>American Society for Microbiology</publisher-name>; <year>1994</year>.</citation>
</ref>
<ref id="bibr143-0300985811429313">
<label>143</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Means</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lien</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>Human Toll-like receptors mediate cellular activation by <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>J Immunol</source>. <year>1999</year>; <volume>163</volume>: <fpage>3920</fpage>–<lpage>3927</lpage>.</citation>
</ref>
<ref id="bibr144-0300985811429313">
<label>144</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mehta</surname>
<given-names>PK</given-names>
</name>
<name>
<surname>Karls</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>White</surname>
<given-names>EH</given-names>
</name>
<etal/>
</person-group> <article-title>Entry and intracellular replication of <italic>Mycobacterium tuberculosis</italic> in cultured human microvascular endothelial cells</article-title>. <source>Microb Pathog</source>. <year>2006</year>; <volume>41</volume>: <fpage>119</fpage>–<lpage>124</lpage>.</citation>
</ref>
<ref id="bibr145-0300985811429313">
<label>145</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mendez</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hatem</surname>
<given-names>CL</given-names>
</name>
<name>
<surname>Kesavan</surname>
<given-names>AK</given-names>
</name>
<etal/>
</person-group> <article-title>Susceptibility to tuberculosis: composition of tuberculous granulomas in Thorbecke and outbred New Zealand White rabbits</article-title>. <source>Vet Immunol Immunopathol</source>. <year>2008</year>; <volume>122</volume>: <fpage>167</fpage>–<lpage>174</lpage>.</citation>
</ref>
<ref id="bibr146-0300985811429313">
<label>146</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Fratti</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Poschet</surname>
<given-names>JF</given-names>
</name>
<etal/>
</person-group> <article-title>Mycobacteria inhibit nitric oxide synthase recruitment to phagosomes during macrophage infection</article-title>. <source>Infect Immun</source>. <year>2004</year>; <volume>72</volume>: <fpage>2872</fpage>–<lpage>2878</lpage>.</citation>
</ref>
<ref id="bibr147-0300985811429313">
<label>147</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mitchison</surname>
<given-names>DA</given-names>
</name>
</person-group>. <article-title>The diagnosis and therapy of tuberculosis during the past 100 years</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2005</year>; <volume>171</volume>: <fpage>699</fpage>–<lpage>706</lpage>.</citation>
</ref>
<ref id="bibr148-0300985811429313">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neyrolles</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Hernandez-Pando</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pietri-Rouxel</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>Is adipose tissue a place for <italic>Mycobacterium tuberculosis</italic> persistence?</article-title> <source>PLoS One</source>. <year>2006</year>; <volume>1</volume>: <fpage>e43</fpage>.</citation>
</ref>
<ref id="bibr149-0300985811429313">
<label>149</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nicholson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bonecini-Almeida Mda</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Lapa e Silva</surname>
<given-names>JR</given-names>
</name>
<etal/>
</person-group> <article-title>Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis</article-title>. <source>J Exp Med</source>. <year>1996</year>; <volume>183</volume>: <fpage>2293</fpage>–<lpage>2302</lpage>.</citation>
</ref>
<ref id="bibr150-0300985811429313">
<label>150</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oddo</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Renno</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Attinger</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Immunol</source>. <year>1998</year>; <volume>160</volume>: <fpage>5448</fpage>–<lpage>5454</lpage>.</citation>
</ref>
<ref id="bibr151-0300985811429313">
<label>151</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ojha</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bhatt</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>GroEL1: a dedicated chaperone involved in mycolic acid biosynthesis during biofilm formation in mycobacteria</article-title>. <source>Cell</source>. <year>2005</year>; <volume>123</volume>: <fpage>861</fpage>–<lpage>873</lpage>.</citation>
</ref>
<ref id="bibr152-0300985811429313">
<label>152</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ordway</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Palanisamy</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Henao-Tamayo</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>The cellular immune response to <italic>Mycobacterium tuberculosis</italic> infection in the guinea pig</article-title>. <source>J Immunol</source>. <year>2007</year>; <volume>179</volume>: <fpage>2532</fpage>–<lpage>2541</lpage>.</citation>
</ref>
<ref id="bibr153-0300985811429313">
<label>153</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Orme</surname>
<given-names>IM</given-names>
</name>
</person-group>. <article-title>The immunopathogenesis of tuberculosis: a new working hypothesis</article-title>. <source>Trends Microbiol</source>. <year>1998</year>; <volume>6</volume>: <fpage>94</fpage>–<lpage>97</lpage>.</citation>
</ref>
<ref id="bibr154-0300985811429313">
<label>154</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ouyang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Kolls</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>The biological functions of T helper 17 cell effector cytokines in inflammation</article-title>. <source>Immunity</source>. <year>2008</year>; <volume>28</volume>: <fpage>454</fpage>–<lpage>467</lpage>.</citation>
</ref>
<ref id="bibr155-0300985811429313">
<label>155</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozaki</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Nakahira</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Tani</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Differential cell analysis in bronchoalveolar lavage fluid from pulmonary lesions of patients with tuberculosis</article-title>. <source>Chest</source>. <year>1992</year>; <volume>102</volume>: <fpage>54</fpage>–<lpage>59</lpage>.</citation>
</ref>
<ref id="bibr156-0300985811429313">
<label>156</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ozeki</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Kaneda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Fujiwara</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> <article-title>In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6′-dimycolate)</article-title>. <source>Infect Immun</source>. <year>1997</year>; <volume>65</volume>: <fpage>1793</fpage>–<lpage>1799</lpage>.</citation>
</ref>
<ref id="bibr157-0300985811429313">
<label>157</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pabst</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Gross</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Brozna</surname>
<given-names>JP</given-names>
</name>
<etal/>
</person-group> <article-title>Inhibition of macrophage priming by sulfatide from <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Immunol</source>. <year>1988</year>; <volume>140</volume>: <fpage>634</fpage>–<lpage>640</lpage>.</citation>
</ref>
<ref id="bibr158-0300985811429313">
<label>158</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandey</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Sassetti</surname>
<given-names>CM</given-names>
</name>
</person-group>. <article-title>Mycobacterial persistence requires the utilization of host cholesterol</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2008</year>; <volume>105</volume>: <fpage>4376</fpage>–<lpage>4380</lpage>.</citation>
</ref>
<ref id="bibr159-0300985811429313">
<label>159</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>XO</given-names>
</name>
<etal/>
</person-group> <article-title>A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17</article-title>. <source>Nat Immunol</source>. <year>2005</year>; <volume>6</volume>: <fpage>1133</fpage>–<lpage>1141</lpage>.</citation>
</ref>
<ref id="bibr160-0300985811429313">
<label>160</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Marzella</surname>
<given-names>L</given-names>
</name>
</person-group>. <article-title>Oxygen tensions and infections: modulation of microbial growth, activity of antimicrobial agents, and immunologic responses</article-title>. <source>Clin Infect Dis</source>. <year>1992</year>; <volume>14</volume>: <fpage>720</fpage>–<lpage>740</lpage>.</citation>
</ref>
<ref id="bibr161-0300985811429313">
<label>161</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pathak</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Basu</surname>
<given-names>KK</given-names>
</name>
<etal/>
</person-group> <article-title>Direct extracellular interaction between the early secreted antigen ESAT-6 of <italic>Mycobacterium tuberculosis</italic> and TLR2 inhibits TLR signaling in macrophages</article-title>. <source>Nat Immunol</source>. <year>2007</year>; <volume>8</volume>: <fpage>610</fpage>–<lpage>618</lpage>.</citation>
</ref>
<ref id="bibr162-0300985811429313">
<label>162</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearl</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Khader</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Solache</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice</article-title>. <source>J Immunol</source>. <year>2004</year>; <volume>173</volume>: <fpage>7490</fpage>–<lpage>7496</lpage>.</citation>
</ref>
<ref id="bibr163-0300985811429313">
<label>163</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pedroza-Gonzalez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Garcia-Romo</surname>
<given-names>GS</given-names>
</name>
<name>
<surname>Aguilar-Leon</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent <italic>Mycobacterium tuberculosis</italic>
</article-title>. <source>Int J Exp Pathol</source>. <year>2004</year>; <volume>85</volume>: <fpage>135</fpage>–<lpage>145</lpage>.</citation>
</ref>
<ref id="bibr164-0300985811429313">
<label>164</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Roman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Roser</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6′-dimycolate</article-title>. <source>J Interferon Cytokine Res</source>. <year>2000</year>; <volume>20</volume>: <fpage>795</fpage>–<lpage>804</lpage>.</citation>
</ref>
<ref id="bibr165-0300985811429313">
<label>165</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peyron</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Vaubourgeix</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Poquet</surname>
<given-names>Y</given-names>
</name>
<etal/>
</person-group> <article-title>Foamy macrophages from tuberculous patients’ granulomas constitute a nutrient-rich reservoir for <italic>M. tuberculosis</italic> persistence</article-title>. <source>PLoS Pathog</source>. <year>2008</year>; <volume>4</volume>: <fpage>e1000204</fpage>.</citation>
</ref>
<ref id="bibr166-0300985811429313">
<label>166</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Portevin</surname>
<given-names>D</given-names>
</name>
<name>
<surname>De</surname>
<given-names>Sousa-D'</given-names>
</name>
<name>
<surname>Auria</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Houssin</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>A polyketide synthase catalyzes the last condensation step of mycolic acid biosynthesis in mycobacteria and related organisms</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2004</year>; <volume>101</volume>: <fpage>314</fpage>–<lpage>319</lpage>.</citation>
</ref>
<ref id="bibr167-0300985811429313">
<label>167</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puissegur</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Lay</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Gilleron</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and beta1 integrin-mediated pathway</article-title>. <source>J Immunol</source>. <year>2007</year>; <volume>178</volume>: <fpage>3161</fpage>–<lpage>3169</lpage>.</citation>
</ref>
<ref id="bibr168-0300985811429313">
<label>168</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quesniaux</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Nicolle</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Torres</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Toll-like receptor 2 (TLR2)–dependent-positive and TLR2-independent-negative regulation of proinflammatory cytokines by mycobacterial lipomannans</article-title>. <source>J Immunol</source>. <year>2004</year>; <volume>172</volume>: <fpage>4425</fpage>–<lpage>4434</lpage>.</citation>
</ref>
<ref id="bibr169-0300985811429313">
<label>169</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radaeva</surname>
<given-names>TV</given-names>
</name>
<name>
<surname>Kondratieva</surname>
<given-names>EV</given-names>
</name>
<name>
<surname>Sosunov</surname>
<given-names>VV</given-names>
</name>
<etal/>
</person-group> <article-title>A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model</article-title>. <source>Tuberculosis (Edinb)</source>. <year>2008</year>; <volume>88</volume>: <fpage>576</fpage>–<lpage>585</lpage>.</citation>
</ref>
<ref id="bibr170-0300985811429313">
<label>170</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Recht</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kolter</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Glycopeptidolipid acetylation affects sliding motility and biofilm formation in <italic>Mycobacterium smegmatis</italic> </article-title>. <source>J Bacteriol</source>. <year>2001</year>; <volume>183</volume>: <fpage>5718</fpage>–<lpage>5724</lpage>.</citation>
</ref>
<ref id="bibr171-0300985811429313">
<label>171</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reed</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Domenech</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Manca</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response</article-title>. <source>Nature</source>. <year>2004</year>; <volume>431</volume>: <fpage>84</fpage>–<lpage>87</lpage>.</citation>
</ref>
<ref id="bibr172-0300985811429313">
<label>172</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reznik</surname>
<given-names>GK</given-names>
</name>
</person-group>. <article-title>Comparative anatomy, physiology, and function of the upper respiratory tract</article-title>. <source>Environ Health Perspect</source>. <year>1990</year>; <volume>85</volume>: <fpage>171</fpage>–<lpage>176</lpage>.</citation>
</ref>
<ref id="bibr173-0300985811429313">
<label>173</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Rich</surname>
<given-names>AR</given-names>
</name>
</person-group>. <source>The Pathogenesis of Tuberculosis</source>. <edition>2nd ed</edition>. <publisher-loc>Springfield, IL</publisher-loc>: <publisher-name>Charles C Thomas</publisher-name>; <year>1951</year>.</citation>
</ref>
<ref id="bibr174-0300985811429313">
<label>174</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riedel</surname>
<given-names>DD</given-names>
</name>
<name>
<surname>Kaufmann</surname>
<given-names>SH</given-names>
</name>
</person-group>. <article-title>Chemokine secretion by human polymorphonuclear granulocytes after stimulation with <italic>Mycobacterium tuberculosis</italic> and lipoarabinomannan</article-title>. <source>Infect Immun</source>. <year>1997</year>; <volume>65</volume>: <fpage>4620</fpage>–<lpage>4623</lpage>.</citation>
</ref>
<ref id="bibr175-0300985811429313">
<label>175</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Riley</surname>
<given-names>RL</given-names>
</name>
</person-group>. <article-title>Aerial dissemination of pulmonary tuberculosis</article-title>. <source>Am Rev Tuberc</source>. <year>1957</year>; <volume>76</volume>: <fpage>931</fpage>–<lpage>941</lpage>.</citation>
</ref>
<ref id="bibr176-0300985811429313">
<label>176</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rios-Barrera</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Campos-Pena</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Aguilar-Leon</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Macrophage and T lymphocyte apoptosis during experimental pulmonary tuberculosis: their relationship to mycobacterial virulence</article-title>. <source>Eur J Immunol</source>. <year>2006</year>; <volume>36</volume>: <fpage>345</fpage>–<lpage>353</lpage>.</citation>
</ref>
<ref id="bibr177-0300985811429313">
<label>177</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivas-Santiago</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Contreras</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Sada</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>The potential role of lung epithelial cells and beta-defensins in experimental latent tuberculosis</article-title>. <source>Scand J Immunol</source>. <year>2008</year>; <volume>67</volume>: <fpage>448</fpage>–<lpage>452</lpage>.</citation>
</ref>
<ref id="bibr178-0300985811429313">
<label>178</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivas-Santiago</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Schwander</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Sarabia</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Human {beta}-defensin 2 is expressed and associated with <italic>Mycobacterium tuberculosis</italic> during infection of human alveolar epithelial cells</article-title>. <source>Infect Immun</source>. <year>2005</year>; <volume>73</volume>: <fpage>4505</fpage>–<lpage>4511</lpage>.</citation>
</ref>
<ref id="bibr179-0300985811429313">
<label>179</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rook</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Dheda</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zumla</surname>
<given-names>A</given-names>
</name>
</person-group>. <article-title>Immune responses to tuberculosis in developing countries: implications for new vaccines</article-title>. <source>Nat Rev Immunol</source>. <year>2005</year>; <volume>5</volume>: <fpage>661</fpage>–<lpage>667</lpage>.</citation>
</ref>
<ref id="bibr180-0300985811429313">
<label>180</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>St John</surname>
<given-names>G</given-names>
</name>
</person-group>, <article-title>Ehrt S, et al. noxR3, a novel gene from <italic>Mycobacterium tuberculosis</italic>, protects <italic>Salmonella typhimurium</italic> from nitrosative and oxidative stress</article-title>. <source>Infect Immun</source>. <year>1999</year>; <volume>67</volume>: <fpage>3276</fpage>–<lpage>3283</lpage>.</citation>
</ref>
<ref id="bibr181-0300985811429313">
<label>181</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ryffel</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Fremond</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Innate immunity to mycobacterial infection in mice: critical role for Toll-like receptors</article-title>. <source>Tuberculosis (Edinb)</source>. <year>2005</year>; <volume>85</volume>: <fpage>395</fpage>–<lpage>405</lpage>.</citation>
</ref>
<ref id="bibr182-0300985811429313">
<label>182</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sada-Ovalle</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chiba</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gonzales</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Innate invariant NKT cells recognize <italic>Mycobacterium </italic>tuberculosis–infected macrophages, produce interferon-gamma, and kill intracellular bacteria</article-title>. <source>PLoS Pathog</source>. <year>2008</year>; <volume>4</volume>: <fpage>e1000239</fpage>.</citation>
</ref>
<ref id="bibr183-0300985811429313">
<label>183</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schindler</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mancilla</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Endres</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF</article-title>. <source>Blood</source>. <year>1990</year>; <volume>75</volume>: <fpage>40</fpage>–<lpage>47</lpage>.</citation>
</ref>
<ref id="bibr184-0300985811429313">
<label>184</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schroeder</surname>
<given-names>CR</given-names>
</name>
</person-group>. <article-title>Acquired tuberculosis in the primate in laboratories and zoological collections</article-title>. <source>Am J Public Health Nations Health</source>. <year>1938</year>; <volume>28</volume>: <fpage>469</fpage>–<lpage>475</lpage>.</citation>
</ref>
<ref id="bibr185-0300985811429313">
<label>185</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seiler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Aichele</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bandermann</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>Early granuloma formation after aerosol <italic>Mycobacterium tuberculosis</italic> infection is regulated by neutrophils via CXCR3-signaling chemokines</article-title>. <source>Eur J Immunol</source>. <year>2003</year>; <volume>33</volume>: <fpage>2676</fpage>–<lpage>2686</lpage>.</citation>
</ref>
<ref id="bibr186-0300985811429313">
<label>186</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherman</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Mdluli</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hickey</surname>
<given-names>MJ</given-names>
</name>
<etal/>
</person-group> <article-title>Compensatory ahpC gene expression in isoniazid-resistant <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>Science</source>. <year>1996</year>; <volume>272</volume>: <fpage>1641</fpage>–<lpage>1643</lpage>.</citation>
</ref>
<ref id="bibr187-0300985811429313">
<label>187</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sieling</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Porcelli</surname>
<given-names>SA</given-names>
</name>
<etal/>
</person-group> <article-title>CD1-restricted T cell recognition of microbial lipoglycan antigens</article-title>. <source>Science</source>. <year>1995</year>; <volume>269</volume>: <fpage>227</fpage>–<lpage>230</lpage>.</citation>
</ref>
<ref id="bibr188-0300985811429313">
<label>188</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Skjot</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Oettinger</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rosenkrands</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group> <article-title>Comparative evaluation of low-molecular-mass proteins from <italic>Mycobacterium tuberculosis</italic> identifies members of the ESAT-6 family as immunodominant T-cell antigens</article-title>. <source>Infect Immun</source>. <year>2000</year>; <volume>68</volume>: <fpage>214</fpage>–<lpage>220</lpage>.</citation>
</ref>
<ref id="bibr189-0300985811429313">
<label>189</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>DW</given-names>
</name>
<name>
<surname>McMurray</surname>
<given-names>DN</given-names>
</name>
<name>
<surname>Wiegeshaus</surname>
<given-names>EH</given-names>
</name>
<etal/>
</person-group> <article-title>Host-parasite relationships in experimental airborne tuberculosis, IV: early events in the course of infection in vaccinated and nonvaccinated guinea pigs</article-title>. <source>Am Rev Respir Dis</source>. <year>1970</year>; <volume>102</volume>: <fpage>937</fpage>–<lpage>949</lpage>.</citation>
</ref>
<ref id="bibr190-0300985811429313">
<label>190</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stead</surname>
<given-names>WW</given-names>
</name>
<name>
<surname>Eisenach</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>Cave</surname>
<given-names>MD</given-names>
</name>
<etal/>
</person-group> <article-title>When did <italic>Mycobacterium tuberculosis</italic> infection first occur in the New World? An important question with public health implications</article-title>. <source>Am J Respir Crit Care Med</source>. <year>1995</year>; <volume>151</volume>: <fpage>1267</fpage>–<lpage>1268</lpage>.</citation>
</ref>
<ref id="bibr191-0300985811429313">
<label>191</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stegelmann</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bastian</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Swoboda</surname>
<given-names>K</given-names>
</name>
<etal/>
</person-group> <article-title>Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Immunol</source>. <year>2005</year>; <volume>175</volume>: <fpage>7474</fpage>–<lpage>7483</lpage>.</citation>
</ref>
<ref id="bibr192-0300985811429313">
<label>192</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stenger</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Niazi</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Modlin</surname>
<given-names>RL</given-names>
</name>
</person-group>. <article-title>Down-regulation of CD1 on antigen-presenting cells by infection with <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Immunol</source>. <year>1998</year>; <volume>161</volume>: <fpage>3582</fpage>–<lpage>3588</lpage>.</citation>
</ref>
<ref id="bibr193-0300985811429313">
<label>193</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stewart</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Rivera</surname>
<given-names>HN</given-names>
</name>
<name>
<surname>Karls</surname>
<given-names>R</given-names>
</name>
<etal/>
</person-group> <article-title>Increased pathology in lungs of mice after infection with an alpha-crystallin mutant of <italic>Mycobacterium tuberculosis</italic>: changes in cathepsin proteases and certain cytokines</article-title>. <source>Microbiology</source>. <year>2006</year>; <volume>152</volume>: <fpage>233</fpage>–<lpage>244</lpage>.</citation>
</ref>
<ref id="bibr194-0300985811429313">
<label>194</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stumhofer</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Laurence</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wilson</surname>
<given-names>EH</given-names>
</name>
<etal/>
</person-group> <article-title>Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system</article-title>. <source>Nat Immunol</source>. <year>2006</year>; <volume>7</volume>: <fpage>937</fpage>–<lpage>945</lpage>.</citation>
</ref>
<ref id="bibr195-0300985811429313">
<label>195</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sturgill-Koszycki</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Schlesinger</surname>
<given-names>PH</given-names>
</name>
<name>
<surname>Chakraborty</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Lack of acidification in <italic>Mycobacterium</italic> phagosomes produced by exclusion of the vesicular proton-ATPase</article-title>. <source>Science</source>. <year>1994</year>; <volume>263</volume>: <fpage>678</fpage>–<lpage>681</lpage>.</citation>
</ref>
<ref id="bibr196-0300985811429313">
<label>196</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tailleux</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Herrmann</surname>
<given-names>JL</given-names>
</name>
<etal/>
</person-group> <article-title>DC-SIGN is the major <italic>Mycobacterium tuberculosis</italic> receptor on human dendritic cells</article-title>. <source>J Exp Med</source>. <year>2003</year>; <volume>197</volume>: <fpage>121</fpage>–<lpage>127</lpage>.</citation>
</ref>
<ref id="bibr197-0300985811429313">
<label>197</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Meinken</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bastian</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens</article-title>. <source>J Immunol</source>. <year>2006</year>; <volume>177</volume>: <fpage>1864</fpage>–<lpage>1871</lpage>.</citation>
</ref>
<ref id="bibr198-0300985811429313">
<label>198</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teitelbaum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Glatman-Freedman</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>A mAb recognizing a surface antigen of <italic>Mycobacterium tuberculosis</italic> enhances host survival</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>1998</year>; <volume>95</volume>: <fpage>15688</fpage>–<lpage>15693</lpage>.</citation>
</ref>
<ref id="bibr199-0300985811429313">
<label>199</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teitelbaum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schubert</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gunther</surname>
<given-names>L</given-names>
</name>
<etal/>
</person-group> <article-title>The M cell as a portal of entry to the lung for the bacterial pathogen <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>Immunity</source>. <year>1999</year>; <volume>10</volume>: <fpage>641</fpage>–<lpage>650</lpage>.</citation>
</ref>
<ref id="bibr200-0300985811429313">
<label>200</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toossi</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Sedor</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Lapurga</surname>
<given-names>JP</given-names>
</name>
<etal/>
</person-group> <article-title>Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis</article-title>. <source>J Clin Invest</source>. <year>1990</year>; <volume>85</volume>: <fpage>1777</fpage>–<lpage>1784</lpage>.</citation>
</ref>
<ref id="bibr201-0300985811429313">
<label>201</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torres</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Ramachandra</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Rojas</surname>
<given-names>RE</given-names>
</name>
<etal/>
</person-group> <article-title>Role of phagosomes and major histocompatibility complex class II (MHC-II) compartment in MHC-II antigen processing of <italic>Mycobacterium tuberculosis</italic> in human macrophages</article-title>. <source>Infect Immun</source>. <year>2006</year>; <volume>74</volume>: <fpage>1621</fpage>–<lpage>1630</lpage>.</citation>
</ref>
<ref id="bibr202-0300985811429313">
<label>202</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsao</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>C</given-names>
</name>
<etal/>
</person-group> <article-title>Increased TNF-alpha, IL-1 beta and IL-6 levels in the bronchoalveolar lavage fluid with the upregulation of their mRNA in macrophages lavaged from patients with active pulmonary tuberculosis</article-title>. <source>Tuber Lung Dis</source>. <year>1999</year>; <volume>79</volume>: <fpage>279</fpage>–<lpage>285</lpage>.</citation>
</ref>
<ref id="bibr203-0300985811429313">
<label>203</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tufariello</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Flynn</surname>
<given-names>JL</given-names>
</name>
</person-group>. <article-title>Latent tuberculosis: mechanisms of host and bacillus that contribute to persistent infection</article-title>. <source>Lancet Infect Dis</source>. <year>2003</year>; <volume>3</volume>: <fpage>578</fpage>–<lpage>590</lpage>.</citation>
</ref>
<ref id="bibr204-0300985811429313">
<label>204</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulrichs</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Moody</surname>
<given-names>DB</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>E</given-names>
</name>
<etal/>
</person-group> <article-title>T-cell responses to CD1-presented lipid antigens in humans with <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Infect Immun</source>. <year>2003</year>; <volume>71</volume>: <fpage>3076</fpage>–<lpage>3087</lpage>.</citation>
</ref>
<ref id="bibr205-0300985811429313">
<label>205</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umemura</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yahagi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hamada</surname>
<given-names>S</given-names>
</name>
<etal/>
</person-group> <article-title>IL-17-mediated regulation of innate and acquired immune response against pulmonary<italic> Mycobacterium bovis</italic> bacille Calmette-Guerin infection</article-title>. <source>J Immunol</source>. <year>2007</year>; <volume>178</volume>: <fpage>3786</fpage>–<lpage>3796</lpage>.</citation>
</ref>
<ref id="bibr206-0300985811429313">
<label>206</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Crevel</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Karyadi</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Preyers</surname>
<given-names>F</given-names>
</name>
<etal/>
</person-group> <article-title>Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities</article-title>. <source>J Infect Dis</source>. <year>2000</year>; <volume>181</volume>: <fpage>1194</fpage>–<lpage>1197</lpage>.</citation>
</ref>
<ref id="bibr207-0300985811429313">
<label>207</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Van Scoy</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Wilkowske</surname>
<given-names>CJ</given-names>
</name>
</person-group>. <article-title>Antimycobacterial therapy</article-title>. <source>Mayo Clin Proc</source>. <year>1999</year>; <volume>74</volume>: <fpage>1038</fpage>–<lpage>1048</lpage>.</citation>
</ref>
<ref id="bibr208-0300985811429313">
<label>208</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>VanHeyningen</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>HL</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>DG</given-names>
</name>
</person-group>. <article-title>IL-6 produced by macrophages infected with <italic>Mycobacterium </italic>species suppresses T cell responses</article-title>. <source>J Immunol</source>. <year>1997</year>; <volume>158</volume>: <fpage>330</fpage>–<lpage>337</lpage>.</citation>
</ref>
<ref id="bibr209-0300985811429313">
<label>209</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vankayalapati</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Klucar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Wizel</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen</article-title>. <source>J Immunol</source>. <year>2004</year>; <volume>172</volume>: <fpage>130</fpage>–<lpage>137</lpage>.</citation>
</ref>
<ref id="bibr210-0300985811429313">
<label>210</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vergne</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Deretic</surname>
<given-names>V</given-names>
</name>
</person-group>. <article-title>Tuberculosis toxin blocking phagosome maturation inhibits a novel Ca2+/calmodulin-PI3K hVPS34 cascade</article-title>. <source>J Exp Med</source>. <year>2003</year>; <volume>198</volume>: <fpage>653</fpage>–<lpage>659</lpage>.</citation>
</ref>
<ref id="bibr211-0300985811429313">
<label>211</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vergne</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Chua</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>HH</given-names>
</name>
<etal/>
</person-group> <article-title>Mechanism of phagolysosome biogenesis block by viable <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>; <volume>102</volume>: <fpage>4033</fpage>–<lpage>4038</lpage>.</citation>
</ref>
<ref id="bibr212-0300985811429313">
<label>212</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Verver</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Warren</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Beyers</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> <article-title>Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2005</year>; <volume>171</volume>: <fpage>1430</fpage>–<lpage>1435</lpage>.</citation>
</ref>
<ref id="bibr213-0300985811429313">
<label>213</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Via</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>PL</given-names>
</name>
<name>
<surname>Ray</surname>
<given-names>SM</given-names>
</name>
<etal/>
</person-group> <article-title>Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates</article-title>. <source>Infect Immun</source>. <year>2008</year>; <volume>76</volume>: <fpage>2333</fpage>–<lpage>2340</lpage>.</citation>
</ref>
<ref id="bibr214-0300985811429313">
<label>214</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vidal</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Pinner</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lepage</surname>
<given-names>P</given-names>
</name>
<etal/>
</person-group> <article-title>Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains</article-title>. <source>J Immunol</source>. <year>1996</year>; <volume>157</volume>: <fpage>3559</fpage>–<lpage>3568</lpage>.</citation>
</ref>
<ref id="bibr215-0300985811429313">
<label>215</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vieira</surname>
<given-names>OV</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>CC</given-names>
</name>
<etal/>
</person-group> <article-title>Acquisition of Hrs, an essential component of phagosomal maturation, is impaired by mycobacteria</article-title>. <source>Mol Cell Biol</source>. <year>2004</year>; <volume>24</volume>: <fpage>4593</fpage>–<lpage>4604</lpage>.</citation>
</ref>
<ref id="bibr216-0300985811429313">
<label>216</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wilkinson</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>DesJardin</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>N</given-names>
</name>
<etal/>
</person-group> <article-title>An increase in expression of a <italic>Mycobacterium tuberculosis</italic> mycolyl transferase gene (fbpB) occurs early after infection of human monocytes</article-title>. <source>Mol Microbiol</source>. <year>2001</year>; <volume>39</volume>: <fpage>813</fpage>–<lpage>821</lpage>.</citation>
</ref>
<ref id="bibr217-0300985811429313">
<label>217</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Reljic</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Naylor</surname>
<given-names>I</given-names>
</name>
<etal/>
</person-group> <article-title>Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs</article-title>. <source>Immunology</source>. <year>2004</year>; <volume>111</volume>: <fpage>328</fpage>–<lpage>333</lpage>.</citation>
</ref>
<ref id="bibr218-0300985811429313">
<label>218</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Witmer</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Fine</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Gionfriddo</surname>
<given-names>J</given-names>
</name>
<etal/>
</person-group> <article-title>Epizootiologic survey of <italic>Mycobacterium bovis</italic> in wildlife and farm environments in northern Michigan</article-title>. <source>J Wildl Dis</source>. <year>2010</year>; <volume>46</volume>: <fpage>368</fpage>–<lpage>378</lpage>.</citation>
</ref>
<ref id="bibr219-0300985811429313">
<label>219</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolday</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hailu</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Girma</surname>
<given-names>M</given-names>
</name>
<etal/>
</person-group> <article-title>Low CD4+ T-cell count and high HIV viral load precede the development of tuberculosis disease in a cohort of HIV-positive Ethiopians</article-title>. <source>Int J Tuberc Lung Dis</source>. <year>2003</year>; <volume>7</volume>: <fpage>110</fpage>–<lpage>116</lpage>.</citation>
</ref>
<ref id="bibr220-0300985811429313">
<label>220</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xirouchaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tzanakis</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Bouros</surname>
<given-names>D</given-names>
</name>
<etal/>
</person-group> <article-title>Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions</article-title>. <source>Chest</source>. <year>2002</year>; <volume>121</volume>: <fpage>815</fpage>–<lpage>820</lpage>.</citation>
</ref>
<ref id="bibr221-0300985811429313">
<label>221</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamura</surname>
<given-names>Y</given-names>
</name>
</person-group>. <article-title>The pathogenesis of tuberculous cavities</article-title>. <source>Bibl Tuberc</source>. <year>1958</year>; <volume>13</volume>: <fpage>13</fpage>–<lpage>37</lpage>.</citation>
</ref>
<ref id="bibr222-0300985811429313">
<label>222</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B</given-names>
</name>
<etal/>
</person-group> <article-title>Human NK cells positively regulate gammadelta T cells in response to <italic>Mycobacterium tuberculosis</italic> </article-title>. <source>J Immunol</source>. <year>2006</year>; <volume>176</volume>: <fpage>2610</fpage>–<lpage>2616</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>